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Glycogen is the storage polysaccharide in a spectrum of organisms ranging from yeast to 
humans. Glycogen has a highly branched structure somewhat resembling a tree or shrub, with the 
branch points formed by glucose molecules being joined by α 1,6-glycosidic linkages. These 
linkages are formed by the action of branching enzyme. Branching of glycogen is critical to 
health, with a lack of branching causing glycogen storage disease type IV, which is fatal in 
humans by age 2. 
While glycogen branching enzyme has been studied in clinical medicine, modulation of 
the enzyme has received comparatively little attention. This dissertation undertook three 
experiments to address whether or not branching enzyme changes in response to dietary 
intervention and supplementation in mouse liver. 
Experiment one focused on the application and refinement of a quantitative assay 
technique for the measurement of branching enzyme activity. The experiment tested the 
reliability of the assay for the first time on a large number (n=68) of subjects. Intraclass 
correlation coefficients revealed that the technique demonstrated high reliability (ICC’s of 0.848, 
0.925, 0.99, and 0.998) for the various assay components. A simplification of the assay method 
was also introduced that increases the economy of the testing protocol. 
Experiment two examined whether or not a dietary intervention resulted in different 
degrees of branching in the liver glycogen of two groups of mice. The results did not show a 
significant difference between mice fed on low-carbohydrate versus high-carbohydrate diets. 
The third experiment investigated whether diet combined with quercetin supplementation 




study, only two groups were significantly different from one another statistically (p = .049). 
These two groups differed only in the time of day the animals were euthanized. Glycogen 
concentration was not different between the two groups. 
Taken together, the experiments provide data indicating that the assay technique is 
reliable. New data pertaining to norms in the degree of branching in mouse liver glycogen are 
reported as well. Future experiments could apply the assay to other tissues such as skeletal 





CHAPTER I – LITERATURE REVIEW 
 
General Introduction 
Virtually every organism from yeast to primates stores carbohydrate in the form of 
glycogen, which can be readily mobilized to meet energy needs during fasting and muscular 
activity. The French physiologist Claude Bernard first identified a starch-like substance in liver 
and muscles and named the substance glycogen, or “sugar former,” in 1870 (1). In the years 
since this discovery, scientific inquiry into the structure and function of glycogen has led to 
discoveries that are recognized as landmarks in modern biology. 
Glycogen was the first biopolymer to be synthesized in a test tube. The first inborn error 
of metabolism attributable to the deficiency of a single enzyme is a glycogen storage disease. 
The mechanism of insulin action has been revealed largely by studies of the control of glycogen 
synthesis and degradation. Among the broad principles emerging from the study of glycogen 
include covalent phosphorylation as a control mechanism in metabolism. Covalent 
phosphorylation was discovered by Carl and Gerty Cori as the mechanism of activation for 
glycogen phosphorylase. With the discovery of glycogen synthase by Leloir and Cardini, another 
enzyme in glycogen metabolism was found to be regulated by phosphorylation, in this case 
inactivated (2). Mitochondrial pyruvate dehydrogenase was then found to be controlled by 
reversible phosphorylation in a fashion similar to that of glycogen synthase. This discovery led 
to the acknowledgment that control by phosphorylation is a recurring theme in biological 
systems, going beyond the bounds of glycogen metabolism. The discovery of cyclic AMP and 
the development of the concept of second messengers emerged due to the investigation of the 




intracellular signaling amplification by the cAMP cascade. Studies on glycogen synthase also led 
to an understanding of the significance of multiple phosphorylations.  
This review will trace the development of some of the key areas of scientific inquiry on 
glycogen metabolism. The review will focus on the mechanisms of glycogen biosynthesis and 
degradation by examining the regulatory proteins involved in the building up and breaking down 
of the glycogen macromolecule. The metabolic pathways of glycogen synthesis and breakdown 
are relatively short. This will allow for a detailed treatment of the enzymes involved and will 
provide a useful framework for understanding how glycogen metabolism is controlled. Also, 
some of the areas of debate and obscurity in the current state of understanding of glycogen 
metabolism will be revealed. 
One area of intense study and vigorous debate in glycogen focused on the mechanisms 
controlling the initiation of glycogen biosynthesis. Since the discovery of phosphorylase by the 
Coris in 1939, it became clear that a primer was required for the synthesis of glycogen from 
individual glucose residues. The exact nature of this primer remained elusive for decades, despite 
intense scientific scrutiny. The determined effort of William Whelan over the course of decades 
finally bore fruit when he discovered that a protein, which he christened “glycogenin” was the 
primer of glycogen synthesis. The first part of this review will provide a detailed account of how 
this discovery was made and the insights into the process of glycogen synthesis that it revealed. 
Close on the heels of the discovery of glycogenin followed the development of a new line 
of investigation into the structure and size of the glycogen particle within the cell. This area of 
investigation led to the proposal that glycogen was not a unitary molecule but rather was 




weight. A nomenclature came to be developed in the literature for these glycogen particles of 
differing molecular weight: the smaller particle was named “proglycogen” and the larger one 
“macroglycogen.” The idea that there could be different forms of glycogen that are actually 
distinct metabolic entities has been controversial. The debate over whether or not there are 
different species of glycogen remains unsettled. The second part of the review examines the 
development of the proglycogen/macroglycogen hypothesis and reviews the literature supporting 
and challenging this concept. 
Following the discovery of glycogen phosphorylase, scientists believed for several years 
that this enzyme controlled both the synthesis and the degradation of glycogen. It was not until 
1957, almost twenty years after the discovery of phosphorylase, that Luis Leloir published his 
classic study that showed that a newly discovered enzyme, glycogen synthase, catalyzed the 
buildup of glycogen via the formation of glycosidic bonds between glucose residues using UDP-
glucose as the activated glucose donor. This was a pioneering moment in biochemistry not only 
because it revealed insights into the process of glycogen biosynthesis but because it was the key 
discovery that led to an understanding of the role of nucleotide sugars in biochemistry. Glycogen 
synthase has been studied extensively since its discovery and the examination of this enzyme 
over the course of several decades has led to greater understanding of mechanisms of metabolic 
control, including reversible phosphorylation and allosteric control. Study of glycogen synthase 
also contributed to our understanding of the mechanisms by which hormones such as insulin, 
glucagon, and epinephrine exert control over metabolism. 
Branching enzyme is required for the synthesis of the glycogen macromolecule. 
Branching is essential to the structure of glycogen; it is the degree of branching seen in the 




encountered in nature, starch. Without the action of the branching enzyme, the glucose polymer 
formed by glycogen synthase demonstrates poor solubility within the cell and precipitates, acting 
as a foreign body. Deficiency of branching enzyme results in glycogen storage disease type IV, 
which is invariably fatal, usually by age 2 in humans. Despite the lethal consequences of a 
deficiency of branching enzyme, the enzyme remains poorly understood in terms of its 
regulation. Branching enzyme has only been the subject of one study pertaining to exercise, 
which reported an increase in the activity of the enzyme in response to an exercise training 
program (3). Any implications of this study have been largely ignored and the findings of the 
study have not been replicated or extended. The review will devote a section to a detailed 
examination of glycogen branching enzyme and will assert that glycogen branching enzyme 
should be studied in more detail. It is of interest to discover more about how glycogen branching 
enzyme is regulated. The current state of knowledge about the enzyme has developed from 
clinical medicine and biochemical studies that have revealed details about the structure of the 
enzyme and its catalytic properties, as well as the development of improved assays and clinical 
screening procedures to detect disease. However, the enzyme is underappreciated in terms of 
how it might be regulated as an adaptation to exercise. This review will set out to place the 
enzyme in context alongside other glycogen cycle enzymes and establish that the enzyme merits 
further study. 
The review will then turn its attention to the degradative arm of glycogen metabolism. 
Glycogen phosphorylase, the rate-limiting enzyme in glycogen breakdown, was the first 
allosteric protein ever discovered. Like glycogen synthase, its study has led to the discovery and 
greater understanding of biological control mechanisms of general significance, such as 




Finally, the review will examine a critical enzyme in the degradation of glycogen, 
glycogen debranching enzyme. Glycogen phosphorylase cannot carry out the complete 
breakdown of glycogen for metabolic energy. The debranching enzyme is required in order for 
the phosphorylase to continue its catalytic action when it approaches four glucose residues away 
from a branch point. As one of the only enzymes to show dual catalytic activities (it is a 
transferase and a glucosidase), debranching enzyme has been of interest to biochemists. A 
deficiency of debranching enzyme causes glycogen storage disease type III, which causes liver 
and muscle pathology but has a milder clinical course than that shown in glycogen storage 
disease type IV, which is a deficiency of the branching enzyme. Like the branching enzyme, 
debranching enzyme has been studied mainly in clinical medicine and biochemistry. Little is 
known about the regulation of the enzyme, as it is thought not to be rate limiting in glycogen 
degradation. However, one study showed that the enzyme increases its activity in response to an 
exercise training program (4). This does provide evidence that the enzyme is regulated and thus 
could be important as an adaptation to exercise. Like branching enzyme, debranching enzyme 
could provide a worthwhile subject for further study. 
The final part of the review will consider in more detail the rationale for a study of 
glycogen branching enzyme. Some possible candidates for experimental models will be 
explored. An assay has been developed for branching enzyme activity that was not available at 
the time that the only study relating branching enzyme to exercise was performed. The 
availability of this improved assay is another reason to revisit branching enzyme in both an 







After the discovery of glycogen phosphorylase in 1939 by Cori and Cori (5), the idea that 
this enzyme catalyzed both the synthesis and the degradation of glycogen in vivo persisted until 
the discovery of glycogen synthase by Leloir and Cardini in 1957 (2). Prior to the discovery of 
glycogen synthase, research revealed that glycogen synthesis did not proceed to a significant 
extent in vitro in the presence of glycogen phosphorylase and glucose 1-phosphate alone without 
the addition of glycogen. This observation prompted the hypothesis that a primer must be 
necessary for the initiation of glycogen synthesis. Following the discovery of glycogen synthase, 
intensive efforts began to determine the smallest saccharide capable of supporting de novo 
biosynthesis of glycogen by this enzyme. 
Although research performed throughout the 1960’s revealed much about the structure, 
function and regulation of glycogen, the molecular means by which the glycogen molecule 
initiated its growth remained obscure. Early indications were that simple maltosaccharides could, 
at least in vitro, act as the primer for glycogen synthesis and that maltotetraose was the smallest 
such saccharide that could prime efficiently (6). However, further investigation into a 
biosynthetic pathway for a maltosaccharide that could act as a primer for glycogen synthesis in 
vivo did not lead to the discovery of a credible mechanism for the formation of such saccharides. 
Some laboratories reported that glycogen could be synthesized without a primer. The data from 
these experiments led to the proposal that the de novo formation of glycogen could proceed 
when glycogen phosphorylase and glycogen synthase were mixed with glucose 1-phosphate and 
UDP-glucose respectively. These experiments could not, however, exclude the possibility of 




Despite the first mention in 1886 by Richard Külz (8) of the possibility that glycogen was 
linked to a protein, substantial progress toward establishing this linkage was not made until the 
1970’s when Krisman and Barengo (9) authored a breakthrough study demonstrating that the 
primer in glycogen synthesis is a protein, which they named “glycogen initiator synthase.” Their 
experiments revealed that when radioactive UDP-glucose was incubated with a liver extract a 
glycogen-like product was formed that precipitated when mixed with trichloroacetic acid (TCA) 
and contained radioactive glucose. The fact that the polysaccharide product formed in this 
reaction precipitated when mixed with acid demonstrated that a protein was covalently linked to 
the primer molecule necessary for the initiation of glycogen synthesis. 
Subsequent experiments then extended the results of the previous work of Krisman and 
colleagues to reveal that in vitro synthesis of glycogen in enzyme systems from rat heart (10) and 
from Escherichia coli (11), Neurospora crassa (12), and bovine retina (13) also yielded 
glycogen bound to a protein. The work done over this period established that the glycogen 
primer was a protein, but the nature of the linkage between the carbohydrate and protein moieties 
of the glycogen macromolecule remained elusive. In 1988, a series of undertaken by Whelan and 
colleagues culminated in the discovery of the nature of the protein-carbohydrate linkage (14). 
After years of effort, the results of these experiments revealed a novel glucose to protein bond 
with the linkage formed between the glucose and the phenolic group of a tyrosine residue on the 
protein (15). 
As multiple laboratories continued work on discovering more about the structure and 
function of this protein primer, more about its nature came to light. Whelan and colleagues 
christened the primer “glycogenin” before the protein had been purified and its structure 




that bound glycogenin to glucose, Cohen and Campbell then were able to sequence glycogenin 
from rabbit skeletal muscle and the primary structure from one species had thus been determined 
(16). 
Since the 1980’s, during which time decades of investigation culminated in the finding 
that glycogenin was the primer of glycogen synthesis, the pace of progress in discovering the 
mechanism by which glycogenin operates and its regulation has accelerated. The laboratories of 
Whelan and Cohen (14, 17) independently isolated muscle glycogenin and found that the protein 
could both glycosylate itself and prime glycogen synthesis – glycogenin and Krisman’s 
“glycogen initiator synthase” were discovered after almost two decades of work to be one and 
the same (18). 
Since the elucidation of the structure of glycogenin, research efforts have yielded new 
insights into how this protein initiates the biosynthesis of glycogen and we have begun to 
understand the role played by glycogenin in determining the rate of glycogen synthesis and the 
structure of the glycogen that is formed. Glycogenin that is unbound to carbohydrate (apo-
glycogenin) has the catalytic ability to self-glycosylate, with Mn2+ as an activator. Once the 
growing glycogen molecule reaches a size of about 10 glucose residues (19), bulk glycogen 
synthesis can then proceed through the actions of glycogen synthase and glycogen branching 
enzyme. There is variation in the number of glucose units that the glycogenin attaches to itself by 
self-glucosylation, with the number of glucose residues added ranging from 7-11 (20). Evidence 
indicates that glycogen functions as a dimer in solution, with one subunit adding glucose 




Lines of inquiry that developed around the same time as the discovery of the catalytic 
mechanism of glycogenin led to the idea that different forms of glycogenin were specific to 
different species and tissues. Initial evidence for the existence of a second mammalian 
glycogenin-like species came from cDNA cloning (22). Definitive evidence for a distinct 
isoform of glycogen appeared in 1998 when Roach and colleagues characterized glycogenin-2, 
which they detected in human liver extracts (23). Further work indicated that this novel isoform 
of glycogenin was found primarily in liver tissue, but also to a lesser extent in the heart and 
pancreas, but not muscle (22). Interestingly, there is evidence that glycogenin-2 is confined to 
primates (24). This goes a long way toward explaining why the existence of this novel species of 
glycogenin remained obscure for as long as it did since research since the discovery of 
glycogenin had not focused on primates but rather on rabbit skeletal muscle and other tissues in 
non-primates. 
The study of glycogenin opened interesting questions about how glycogen accumulation 
within the cell is regulated. Among other things, as more information became available about 
glycogenin, evidence emerged suggesting that glycogen existed in vivo in distinct pools that were 
separable by molecular weight and acid-solubility. This observation led to the naming of a low 
molecular weight glycogen particle that appeared to be a stable intermediate in glycogen 
synthesis: “proglycogen” (25). Subsequent sections of this review will provide more detail about 
proglycogen. 
Naturally, the discovery of glycogenin raised questions about its possible role as a 
regulator in the rate of glycogen synthesis. Despite the glycogenin’s attractiveness as a candidate 
in controlling the rate of flux during glycogen synthesis, experimental evidence has not 




obtained from experiments performed with rats and humans did not reveal a correlation between 
glycogen levels and glycogen amount or activity in muscle nor was there an observable increase 
in either glycogenin-1 protein or mRNA expression at rest, at exhaustion, or during recovery 
from exercise (26, 27). 
Other avenues of research interest into glycogenin include the discovery of a protein that 
seems to play a role in regulating glycogenin itself. This protein has been named glycogen 
interacting protein (GNIP). GNIP appears to play a role in stimulating glycogenin by changing 
the spatial orientation of the glycogenin dimers, which could be necessary for initiating the self-
glucosylation reaction (28, 29). It is also of interest to know whether or not glycogenin can 
translocate within the cell. An ability to change location in response to changing conditions 
within the cell could indicate that glycogenin could be recruited to areas where glycogen could 
be in high demand. Data has emerged showing that GNIP and glycogenin can bind to desmin and 
actin, respectively, and this could provide a means by which these proteins are recruited to 
specific locations within the muscle according to glycogen demand (29, 30). 
The discovery that glycogenin is the primer for glycogen synthesis was a landmark 
finding that led to a greatly enriched understanding of exactly how glycogen synthesis begins. 
Along with the elucidation of its structure and catalytic mechanism, learning more about 
glycogenin prompted fruitful inquiry into determining how the rate of glycogen synthesis is 
controlled and in what subcellular locations the glycogen granule is formed. Questions about the 
regulation of glycogenin activity remain open and further investigation into the possible ability 
of glycogenin to translocate within the cell offer some directions for further study that will add to 




Proglycogen and Macroglycogen 
As work proceeded investigating the nature of the primer in glycogen biosynthesis, 
interesting observations about the structure of the glycogen macro-molecule began to surface. 
Glycogen appeared to exist not as a singular molecular entity, but in distinct pools. Early reports 
indicated that glycogen turnover in skeletal muscle and liver did not proceed at a constant rate 
and that the differing rates of glycogen breakdown observed bore a relationship to the differing 
molecular weights of the glycogen granules within a given tissue (31, 32). 
 Long experience had shown that different chemical techniques for isolating glycogen 
from tissue extracts yielded differing amounts of glycogen. Isolating glycogen from tissue 
samples with hot alkali was a time-honored practice (notwithstanding how such treatment 
degrades proteins and set the search for glycogenin back by decades, perhaps). It had also been 
clear dating back to at least the 1950’s (33) that glycogen particles of different molecular weights 
varied in their solubility in acid (34). Authors also noted that the amounts of acid-soluble 
glycogen differed according to the tissues from which glycogen was isolated (6, 16, 25, 31-34). 
In the early stages of research on glycogen, the observed variations in the amount of glycogen 
isolated from different tissues by using either hot alkali or dilute TCA led to the development of 
a bewildering terminology for glycogen. The fraction of glycogen isolated by hot alkali (KOH) 
treatment came to be known as “fixed,” “bound,” “desmo-,” and “difficultly extractable.” On the 
other hand, the fraction isolated by cold TCA precipitation was identified variously as “free,” 
“lyo-,” “trichloroacetic-acid extractable,” and “easily extractable” (35). 
It became clear during this time that the liver and skeletal muscle differed noticeably in 
the amount of “fixed” and “free” glycogen that could be extracted from each tissue. The 




“free” glycogen, while in skeletal muscle the “fixed” glycogen was the more abundant form (33). 
Work progressed during the 1950’s largely influenced by the classification scheme of “fixed” 
and “free” glycogen until experiments done in 1960 led to the virtual abandonment of the idea 
that there were structurally and functionally distinct pools of glycogen. Roe and colleagues used 
different homogenization techniques to examine the fractions of liver, muscle, and heart 
glycogen that could be extracted by TCA precipitation without hot alkali compared to that 
fraction which could be isolated using additional KOH following TCA precipitation. They found 
that if homogenization beads were used then the additional step of hot alkali treatment yielded no 
more glycogen than the amount extracted by cold TCA precipitation alone (35). 
Investigation of differing pools of glycogen classified according to acid solubility 
reached an apparent zenith at the end of the 1950’s. After the experiments of Roe and colleagues 
(35) questioned whether the extraction procedure might have been a source of error in 
experiments suggesting distinct species of glycogen, the concept of “desmo-“ and “lyo-“ 
glycogen fell from favor. Prevailing opinion shifted away from the notion that glycogen existed 
in metabolically distinct pools. Prior experimental evidence supporting this paradigm was 
dismissed as artifact arising from methods used to isolate glycogen from tissue samples. At this 
point, work on the topic of separate pools of glycogen classified by acid solubility largely 
ceased. 
As work progressed on revealing the nature of glycogenin, however, some laboratories 
began to revisit the hypothesis that there were metabolically and structurally distinct species of 
glycogen. The discovery that the protein glycogenin was indeed the primer of glycogen synthesis 
not only validated the hypothesis proposed in 1886 by Külz that glycogen was bound to protein 




hypothesis of desmo- and lyo-glycogen (36). This time a new term would be introduced to the 
scientific lexicon: “proglycogen.” 
The work performed in the laboratory of Whelan and co-workers proved instrumental in 
formulating the concept of proglycogen and macroglycogen. In the course of their experiments 
leading to the discovery of glycogenin, it became clear that glycogenin existed as a covalently 
bound component of glycogen, linked to glycogen by a novel glucose linkage to tyrosine 194 on 
the glycogenin protein. However, Whelan also identified a glycogen-free form of glycogenin 
that, upon purification, proved to be an autocatalytic protein (14, 17). They referred to this 
glycogenin-like protein as self-glucosylating protein (SGP). Further work examining SGP 
revealed that filtered muscle extracts contained a protein that underwent glucosylation but that 
SDS-PAGE and radioautography demonstrated that the glucosylated protein was not SGP but 
rather a molecule with a much higher molecular weight of approximately 400 kDa. This entity, 
which they called p400, then became a target of investigation in an effort to clarify the 
biosynthetic pathway leading from glycogenin to “classic” or depot glycogen. 
Preliminary observations from experiments done with p400 showed that when the 
molecule was incubated with UDP[14C]glucose there was a resulting breakdown of p400 into a 
series of glucoproteins with molecular weights descending down to 37 kDa (p37), the same as 
glycogenin. P400 also proved to be subject to breakdown by amylase, which accelerated the 
conversion of p400 into p37 (25). Prior to the finding of p400 in muscle extracts, Whelan’s 
laboratory had discovered its presence in adipocytes and a rat mammary tumor but there was no 
apparent connection to glycogenin because there was no breakdown of p400 into p37 in these 




At this stage, the discovery of glycogenin and the identification of glycogen-like 
molecules of different molecular weights revealed by gel electrophoresis and separable by acid 
solubility lent credence to speculation that there might be discrete pools of glycogen that exhibit 
distinct metabolic behavior. The next set of experiments undertaken by Whelan and colleagues 
helped to clarify the path from p37 to p400 and concluded that p400 was a distinct species of 
glycogen. 
Extracts of rabbit skeletal muscle were glucosylated in the presence of various activators 
and inhibitors of glycogen synthase and SGP. The data from these experiments led the authors to 
conclude that glucose residues were added to p400 by a glycogen synthase-like enzyme and also 
that p37, a lower molecular weight glucoprotein, was glucosylated by a different enzyme acting 
by autocatalysis. This set of experiments also provided evidence that glycogenin does not exist in 
the free state in skeletal muscle but rather is present in p400 and macro-molecular glycogen 
concurrently. The overall picture that emerged from this data was that glycogenin is built up by 
adding glucose residues by autocatalysis up to molecular weight of approximately 50 – 80 kDa 
and then grows further by adding glucose residues in reactions catalyzed by a synthase. SDS-
PAGE and TCA precipitation allowed the isolation of a seemingly distinct pool of glycogen of a 
low molecular weight (400 kDa) that is acid-insoluble. This pool of glycogen, referred to 
previously as p400, was designated “proglycogen” (25). 
Several implications arose out of this hypothesis of distinct pools of glycogen. Whelan 
suggested that different forms of glycogen synthase might be acting to synthesize proglycogen 
from SGP and glycogen from proglycogen. The key observation supporting this conclusion was 
that the synthesis of proglycogen from SGP proceeded rapidly in the presence of glucose 6-




required for the synthesis of the classic macro-molecular glycogen by glycogen synthase requires 
milli-molar concentrations of UDP-glucose (25). Additional support for the concept of a 
different enzyme building up proglycogen from SGP was provided by demonstrating that 
glucosylation of SGP proceeded rapidly in the presence of micro-molar UDP-glucose but 
required a different activator than the synthase, Mn2+ (14, 17). 
 While the structure of proglycogen seemed similar to glycogen, results from the 1990 
experiments suggested that proglycogen is glucosylated preferentially in the presence of 
glycogen (25). The possibility also emerged that any assay of glycogen in tissue represents an 
average of pro- and macroglycogen and that new assays for each type of glycogen should be 
devised. The report of Whelan and colleagues in which the authors coined the term 
“proglycogen” and put forth the idea that a “proglycogen synthase” could be acting selectively to 
assemble proglycogen from SGP was a milestone in the study of glycogen biosynthesis. This 
new perspective fostered the development of new lines of inquiry that significantly refined our 
understanding of how glycogen synthesis proceeds; it also opened up a debate about the concept 
of pro- and macroglycogen that continues currently. 
Several laboratories extended and refined the hypothesis proposed by Whelan that 
glycogen exists in distinct pools distinguishable by molecular weight, acid solubility, and 
metabolic behavior within the cell. One of the first studies that clarified the steps in the synthesis 
of glycogen from SGP to macroglycogen was carried out once again in the laboratory of Whelan 
and colleagues. Using cultured astrocytes from rats, the authors provided evidence that the path 
of glycogen synthesis followed this sequence: glycogenin → proglycogen → macroglycogen 
(38). These experiments, which used NH4+ in combination with re-feeding of [14C] glucose to 




in glycogen synthesis and that glycogen-depleted astrocytes begin the rapid re-synthesis of 
glycogen by glucosylation of SGP to form proglycogen. In the presence of NH4+, glycogen 
synthesis proceeded up to the point of proglycogen, but no further. In astrocytes untreated with 
NH4+, synthesis proceeded from proglycogen to macroglycogen. This observation led the authors 
to conclude that different glucosyl transferases act to catalyze each pathway. The experiments 
also provided evidence of a clear precursor-product relationship between proglycogen and 
macroglycogen. 
After the publication of Whelan’s experiments using astrocytes as a model system, other 
laboratories began to examine several aspects of glycogen metabolism from perspectives that 
reflected a growing acceptance of the concept of pro- and macroglycogen. One of the most 
prominent lines of inquiry concerned the process of glycogen biosynthesis under different 
conditions in skeletal muscle. These studies refined understanding of the time course of glycogen 
re-synthesis after glycogen depletion and also helped to clarify steps in the process of glycogen 
synthesis in vivo from glycogenin to macro-molecular glycogen. 
While the question of whether proglycogen and macroglycogen are separate molecular 
entities remained open, studies using the device of separating glycogen into different fractions 
according to molecular weight and acid solubility proved useful in revising accepted concepts of 
glycogen synthesis. Prior to Whelan’s proposal of the proglycogen concept, prevailing 
knowledge maintained that glycogen synthesis was a unitary phenomenon regulated mainly by 
glycogen synthase. The rate of glucose uptake into the cell had also been recognized as a 




The concept of proglycogen – macroglycogen led to development of a more sophisticated 
picture of glycogen synthesis. The work of laboratories such as that of Graham and colleagues 
revealed in greater detail the biphasic (44) character of glycogen synthesis in skeletal muscle 
(45-49). These experiments, along with the work of Huang and colleagues (50), provided 
evidence that in glycogen-depleted muscle the early phase of glycogen repletion results from an 
increase in the quantity of proglycogen. As glucose uptake continues and glycogen synthesis 
proceeds, the ratio of macroglycogen to proglycogen increases. Adamo and Graham (49) 
reported that the MG:PG ratio changed from 13:87 to 25:75 as the total glycogen concentration 
increased from 43.8 mmol/kg dw to 340.2 mmol/kg dw. This finding was in accordance with 
earlier observations by Jansson (34) comparing acid-soluble and insoluble fractions of glycogen 
in human skeletal muscle before the term proglycogen had been introduced into the literature. As 
glycogen concentration increases, there seems to be a glycogen concentration (350 mmol/kg dw) 
above which increases in total glycogen appear to be mainly due to increases in macroglycogen. 
At low glycogen concentrations, several studies have provided evidence that proglycogen is 
more dynamic than macroglycogen (46, 48-52). This body of evidence indicates that in 
glycogen-depleted muscle, the restoration of glycogen stores follows a time course during which 
proglycogen is replenished before macroglycogen and that as glycogen stores are built up, 
macroglycogen represents an ever greater portion of the total glycogen concentration. The 
buildup of glycogen stores to levels greater than normal resting levels, known as 
supercompensation, appears to result from the accretion of macroglycogen rather than 
proglycogen (52). 
The introduction of the proglycogen - macroglycogen hypothesis also stimulated interest 




to explain how glycogen fractions could be utilized during exercise. The first hypothesis held 
that proglycogen is the most dynamic fraction of glycogen and is utilized preferably as a 
substrate for exercise while macroglycogen exists as a relatively inactive storage form. The 
second hypothesis maintained that proglycogen is a stable intermediate and that glycogenolysis 
breaks down macroglycogen as a preferred fuel source with proglycogen as a stopping point. 
Alternatively, proglycogen and macroglycogen are used at equal speeds and the breakdown of 
each is not a consequence of any functional difference between either fraction but is determined 
rather by the availability of each. 
The body of work done to this point regarding regulation of glycogen metabolism during 
exercise leaves several questions open, despite the progress made over the last decade. The 
relative contributions of the proglycogen and macroglycogen fractions as a substrate for exercise 
appear to be contingent upon initial glycogen concentration before the onset of exercise, the 
intensity level of the exercise, whether the exercise is single- or repeated-bout, and the species of 
animal under investigation. 
 The general picture emerging is that when performing mild to moderate intensity 
endurance exercise, proglycogen and macroglycogen can both be utilized, with initial glycogen 
concentration being a significant factor determining the extent to which each glycogen fraction is 
degraded (52-59). Derave and colleagues found that in rats initial macroglycogen concentration, 
but not that of proglycogen, was correlated with the rate of glycogenolysis in electrically 
stimulated skeletal muscle (53). 
 The species under study is a source of variation in degradation of the different glycogen 




humans (56, 57). Data also suggest that horses store a greater amount of macroglycogen than 
humans (56). Data from humans indicates that proglycogen is the more dynamic of the two 
fractions in that the rate of glycogenolysis during exercise appears to be greater in the 
proglycogen fraction at all levels of exercise intensity studied thus far (54, 55). Endurance 
exercise of a long duration (marathon running) has to date been the only exercise modality 
studied that has resulted in macroglycogen being degraded to a greater degree than proglycogen 
in humans (52). Shearer and colleagues have also reported that macroglycogenolysis in humans 
can be greatly suppressed when repeated bouts of exercise are performed (55). 
Various authors (47, 54-57) have also speculated that patterns of pro- and macrogenolysis 
are subject to a mechanism specific to muscle fiber-type. To date, the research done has been 
insufficient to clarify this question. Exercise protocols utilized have certainly resulted in the 
recruitment of Type I and Type IIa muscle fibers, with a study done by Brojer and colleagues on 
horses performing maximal treadmill exercise showing evidence that Type IIb fibers were also 
recruited (56). The authors speculate that proglycogen might be preferentially degraded in Type 
IIb fibers, which would explain their finding that greater breakdown of proglycogen occurred 
during maximal exercise in horses versus greater macroglycogen utilization during endurance 
exercise. In addition to fiber type, the heterogeneity in the location of the glycogen granule has 
been put forward as a possible factor determining glycogen degradation patterns in skeletal 
muscle (60). 
Currently, there is evidence to support the conclusion that proglycogen is a dynamic 
source of substrate in exercising muscle under almost all conditions (54, 55), with 
macroglycogen being degraded under conditions of relatively moderate exercise intensity and 




forces the mobilization of macroglycogen stores (52). High intensity exercise appears to increase 
the rate of breakdown of proglycogen (54, 56), although the underlying mechanism of this 
observation remains to be explained. The influence of muscle fiber type on the pattern of 
glycogen degradation is a topic that merits further investigation. Future studies in this direction 
might help to clarify the functional differences between the two fractions of glycogen and would 
help to settle the question of whether pro- and macroglycogen are under different enzymatic 
regulation, as proposed by Whelan and colleagues (6, 25, 38, 61). 
The debate over whether proglycogen and macroglycogen are distinct molecular entities 
deserves mention before concluding the discussion on these two fractions of the glycogen pool. 
Several authors have challenged the hypothesis that proglycogen and macroglycogen represent 
different species of glycogen (62-64). 
The main support for the concept of proglycogen lies in its insolubility in dilute acid, 
which is the basis for making a distinction between it and “classic” or depot glycogen, which is 
acid-soluble. The idea that proglycogen is of a discrete molecular weight of 400 kDa is also 
central to the proglycogen – macroglycogen paradigm. Experimental evidence challenging this 
hypothesis arises from an assertion that the glycogen extraction technique used by the 
laboratories performing the first several experiments with pro- and macroglycogen overestimated 
the amount of acid-insoluble glycogen and thus underestimated the fraction of “classic” glycogen 
(63, 64). The issue revolved around whether or not the muscle tissue extracts had been 
homogenized prior to the measurement of pro- and macroglycogen. Homogenization of the 
tissue extracts disrupts the tissue and would conceivably allow more of the total glycogen in the 
extract to be measurable. The authors using the homogenization treatment maintain that use of a 




reticulum and the dense mesh of myofibrils where most glycogen particles are found (65, 66). 
James and colleagues also provide evidence that the acid-insoluble fraction of glycogen does not 
correspond to a pool of glycogen of low molecular weight (66). 
Proglycogen, Macroglycogen, and Exercise 
The preponderance of research on pro- and macroglycogen has not focused on exercise 
per se, however, a small body of literature has developed since the late 1990’s that has sought to 
explain the roles of different glycogen fractions in exercise. The results of several studies on 
exercise and proglycogen and macroglycogen are summarized in Table 1.1 below. 
Table 1.1 Summary of Studies with Exercise 
and Proglycogen/Macroglycogen 
   
Author and year Purpose Subject Description Results 
Adamo et al, 1998 Determine whether two structural forms of 
glycogen (PG and MG) function as different 
metabolic pools 
Nine human males PG and MG metabolized 
differently in timing and 
magnitude, both are sensitive 
to diet 
 
Asp et al, 1999 Assess how MG and PG fractions are 
restored after a marathon and to determine 
whether glycogen accumulates differently 
in various fiber types 
Six marathon runners MG is used to greater degree 
during marathon than PG and 
is slower to replete than PG 
after marathon; glycogen 
repletion delayed in slow-
twitch fibers compared to fast 
twitch 
 
Derave et al, 2000 Investigate relative contributions of PG/MG 
to glycogenolysis during muscle contraction 
Rats (n=25) Both PG and MG are 
degraded; when glycogen 
stores are amply available MG 
is preferentially utilized 
 
Shearer et al, 2001 Examine relationship between pre-exercise 
muscle glycogen content and utilization of 
PG and MG 
Six male humans Initial glycogen concentration 
regulates glycogenolysis in 
PG and MG pools; PG 
preferentially utilized at onset 
of exercise when glycogen 
concentration is high. Lower 
glycogen levels and repeated 
exercise result in equal 







While new evidence has emerged to challenge the hypothesis that proglycogen and 
macroglycogen are distinct molecular entities, there is support for considering the molecular 
weight of glycogen fractions under certain conditions. While “proglycogen” and 
“macroglycogen” might best be viewed as purely operational terms and not separate species of 
glycogen, the introduction of the terms into the nomenclature has stimulated renewed interest in 
the mechanisms controlling the synthesis and degradation of glycogen.  
Whether or not the fractions of glycogen referred to as pro- and macroglycogen are 
indeed separate molecular entities or even truly correspond to pools of glycogen that differ in 
molecular weight, data supports the idea that different fractions of glycogen respond differently 
to metabolic stimuli (67). The proglycogen concept has undoubtedly led to insights that reveal a 
significantly more complex regulation of glycogen than had been supposed even two decades 
ago. The data from the studies employing the proglycogen – macroglycogen paradigm have 
Author and year Purpose Subject Description Results 
Graham et al, 2001 Assess changes in PG and MG under 
varying exercise intensities and durations 
21 human males PG appears more dynamic and 
is utilized preferentially in 
more situations than MG; 
rates of glycogenolysis 
consistently higher in PG 
fraction 
 
Essen-Gustavsson et al, 
2002 
Study effect of an endurance race on PG 
and MG fractions 
Seven endurance 
trained horses 
MG was utilized to a greater 
degree than PG during an 
endurance race 
 
Brojer et al, 2002 Investigate degradation of PG and MG 
during intense treadmill exercise 
Ten standard-bred 
trotter horses 
PG and MG contribute equally 
to glycogenolysis during 
intense exercise; resynthesis 
starts in PG pool 
 
Brojer et al, 2006 Determine resynthesis of PG and MG in 




MG resynthesized faster 
during first 24 hrs post-
exercise; equal rates of 





pointed to new directions for understanding how glycogen is regulated. Recently, attention has 
turned toward investigating how the variable subcellular location of glycogen and its interaction 
with scaffolding proteins and enzymes control the flux of glycogen in response to changing 
metabolic conditions. 
Glycogen Synthase 
After the discovery of glycogen phosphorylase by the Coris in 1939, the prevailing 
knowledge at the time maintained that phosphorylase not only controlled glycogen degradation 
but also that this enzyme was responsible for glycogen synthesis. As work progressed, it became 
clear that in vitro synthesis of glycogen could not proceed to a significant extent when only 
glycogen phosphorylase and glucose 1-phosphate were present in the reaction mixture (68). This 
observation led to the conclusion that a primer was necessary for the synthesis of glycogen. 
While the elucidation of the primer for glycogen biosynthesis awaited the discovery of 
glycogenin by the team of W.J. Whelan in the 1980’s, Leloir and Cardini discovered glycogen 
synthase in 1957 and thereby clarified that different enzymatic systems were responsible for the 
biosynthetic and degradative arms of glycogen metabolism (2). Since the discovery of glycogen 
synthase, the enzyme has been the subject of a voluminous body of scientific inquiry. This 
review will, however, primarily focus on the research pertaining to the role of glycogen synthase 
in exercise while also aiming to provide an overview of the work done pertaining to how GS is 
regulated. 
Glycogen synthase is a key enzyme in glycogen synthesis. This enzyme catalyzes the 
addition of glucose residues in a linear chain bound by alpha 1-4 linkages between individual 




complex and is mediated by several kinases and phosphatases that covalently modify the enzyme 
by reversible phosphorylation. Additionally, the enzyme is subject to allosteric regulation by the 
binding of glucose 6-phosphate (69). 
The various signaling events that trigger modification of glycogen synthase by 
phosphorylation are coordinately regulated by variable hormonal concentrations. Insulin, 
glucagon, catecholamines, and glucocorticoids are all involved in regulating the activity of 
glycogen synthase and allow for flexible and finely tuned regulation of glycogen synthesis under 
highly variable conditions. The energy charge of the cell as determined by the AMP/ATP ratio 
and the nutritional status of the organism are two key stimuli that regulate the activity of GS. The 
concentration of glycogen is also a potent control mechanism of GS activity. High glycogen 
concentrations inhibit GS, while low glycogen concentrations stimulate GS activity. There is also 
evidence that the location of GS within the cell is not fixed and that GS translocates to different 
subcellular locations dependent on the relative abundance or scarcity of glycogen depots within 
the cell and the cell’s energy state (70). The following section will highlight some of the more 
important work that has been done in elucidating the many levels of regulation of GS. 
Glycogen Synthase Regulation 
Glycogen synthase has been viewed as the rate-limiting step in the synthesis of glycogen, 
although there is still debate regarding whether glucose transport or glycogen synthase is truly 
the flux controlling step (19, 71). Although this question has not yet been conclusively settled, a 
large body of evidence indicates that GS contributes significantly to controlling the rate of 




regulated in an effort to place GS in its proper context within a broader discussion of glycogen 
metabolism. 
Glycogen synthase regulation is complex and the mechanisms controlling the enzyme are 
not fully understood. The complexity of GS regulation reflects the important role of GS in 
metabolic regulation. GS activity is known to be regulated by reversible phosphorylation and 
allosteric activation by glucose 6-phosphate. Several external stimuli such as insulin, 
catecholamines, glycogen content, and exercise also exert an influence on GS activity by 
changing phosphorylation state and the concentration of allosteric activators. 
One level of control of GS is reversible phosphorylation. Phosphorylation of GS inhibits 
the enzyme. Investigators have thus far identified nine well-documented phosphorylation sites 
(72-74). While an exhaustive list of all the kinases that phosphorylate GS goes beyond the scope 
this review, some of the kinases reported to phosphorylate various sites in GS include: GSK-3, 
AMPK, PKA, phosphorylase kinase, CaM-kinase II, and casein kinase (72, 73, 75-77). Among 
these kinases, GSK-3, AMPK, and PKA all have physiological significance in regulating GS. It 
is noteworthy to mention that the nine phosphorylation sites identified on GS theoretically allow 
for 512 possible combinations of phosphorylation configurations, but due to hierarchal 
phosphorylation it is highly likely that there are far fewer combinations possible in vivo (72). 
Even so, the number of possible phosphorylation combinations still allows for complex layers of 
regulation of GS and possible redundancy of control of the enzyme. Such intricate regulation of 
GS is evidence of the central role played by the enzyme in glycogen metabolism. 
Although a complete understanding of the roles played by these several kinases in 




how some of the phosphorylation sites influence activity. In particular, the laboratories of Cohen 
and Roach have provided insight into the actions of epinephrine and insulin in modifying the 
phosphorylation of several serine residues on GS. Epinephrine increases phosphorylation of 
several serine residues, thus reducing GS activity, while insulin reduces phosphorylation of 
several of the same serine residues, thereby increasing activity of the enzyme (72, 73). 
While a significant amount of research attention has focused on the phosphorylation state 
of GS and the many kinases that phosphorylate GS, it is also important to recognize the role 
played by glucose 6-phosphate in regulating the activity of GS. GS activity in the presence of 
high levels of glucose 6-phosphate remains high regardless of the phosphorylation state of GS. 
However, the concentration of glucose 6-phosphate required to stimulate GS activity to its 
maximal rate is far above the physiological range of 0.1-0.2mM in muscles (74). The sensitivity 
of GS to glucose 6-phosphate is also controlled by the form of GS, which predominates in a 
tissue at any given time. GS is known to exist in two interconvertible forms. The I-form of the 
enzyme is active independently of glucose 6-phosphate. The inactive D-form, on the other hand, 
is dependent on glucose 6-phosphate for its activation.  The conversion of GS between the two 
forms is dependent on the phosphorylation state of the enzyme, which is determined by 
hormonal signals from insulin and epinephrine, glycogen content, and muscle contraction. 
Insulin activates GS and increases glycogen synthesis by decreasing phosphorylation of GS and 
by increasing the concentration of glucose 6-phosphate. Epinephrine inhibits GS and reduces 
glycogen synthesis by increasing phosphorylation of GS and blocking insulin-mediated 
activation of GS. Epinephrine also reduces the affinity of GS for its allosteric activator, glucose 





The study of the interplay of these factors in regulating GS has led to the development of 
insights into glycogen metabolism and has prompted inquiry into which of the various control 
mechanisms are most important in controlling the net rate of glycogen synthesis. A particularly 
active area of research has focused on the relative importance of glucose transport into the cell 
versus the action of glycogen synthase as the dominant flux-controlling step in the synthesis of 
glycogen. 
While GS has been viewed as the rate-limiting step in glycogen synthesis, challenges 
have emerged to this concept, proposing that glucose transport and phosphorylation of glucose 
by hexokinase are the rate-limiting steps in glycogen synthesis. The experimental basis for this 
assertion has arisen largely from the work done in the laboratory of Shulman and Rothman. 
Using nuclear magnetic resonance (NMR) to conduct in vivo experiments using humans and 
rodents, the authors concluded that glucose transport and not GS was the flux-determining step 
(78-80). They based their conclusions on the experimental findings from their work and several 
other studies that indicated a mismatch between the rate glycogen synthesis in vivo and the rate 
attributable to the degree of phosphorylation of GS observed in vitro (81-83). From these data, 
the authors propose that by taking into account the degree of phosphorylation of GS in 
conjunction with the in vivo concentrations of glucose 6-phosphate and ATP a quantitative 
agreement between the in vitro rate of glycogen synthesis observed in the GS assay and the in 
vivo rate observed during NMR studies can be obtained. The conclusion that glucose 6-
phosphate concentrations are critical in determining the rate of glycogen synthesis in vivo is to 
say that glucose transport is a rate-limiting step in glycogen synthesis. This is due to the fact that 
glucose 6-phosphate concentration in the cell is limited by glucose transport because glucose is 




muscle cell, thereby trapping the glucose within the cell. From this point, glucose 6-phosphate 
can undergo many fates within the cell and is the key allosteric activator of GS. 
Experimental evidence also supports a role for GS as the flux-determining step in 
glycogen synthesis. Experiments with transgenic mice overexpressing an active form of 
glycogen synthase showed that the animals expressing the mutant GS had a marked increase in 
glycogen synthesis independently of glucose transport compared to controls (84). Further 
evidence supporting a rate-determining role for GS came from the in vivo glucose-clamp 
analyses of Rossetti and Hu (85). These experiments showed that GS activation occurs in vivo at 
insulin levels lower than that required to stimulate glucose uptake and that even at insulin 
concentrations that were insufficient to result in glucose uptake or glycogen accumulation GS 
activity was sufficient to prevent net glycogenolysis by stimulating reincorporation of glucose 
equivalents into glycogen. These results indicate that GS activity is important in controlling flux 
of glucose into glycogen independent of glucose transport. It has also been noted that increased 
insulin decreases both UDP-glucose and glucose 6-phosphate prior to activation of glucose 
transport (85). This observation supports the notion that insulin-activated GS can “pull” glucose 
in the direction of glycogen synthesis before glucose is “pushed” into the cell by insulin-
activated glucose transport. This concept is supported by experiments with cut muscle fibers, 
which allow glucose entry by simple diffusion (86). When glucose uptakes were held constant by 
varying the concentration of glucose in the medium, glycogen synthesis was higher in insulin-
treated preparations, indicating that insulin-stimulated GS activity directs intracellular glucose 
into glycogen. 
From the foregoing evidence, it is perhaps most prudent to conclude that both GS activity 




provides an attractive method for examining glycogen metabolism due to its being non-invasive 
and therefore well-suited to human experiments. Interpretation of the results from NMR studies 
can be difficult to interpret however, due to the limitation of the method in dealing with 
variations in the spatial distribution of metabolites in cells and tissues (19). There is substantial 
evidence for a central role of GS in controlling the rate of glycogen synthesis, although the 
interpretation of data from transgenic animals applied to control populations has caveats. It is 
difficult to control for compensatory mechanisms arising in transgenic animals as a response to 
genetic mutation that can confound the results of experiments and limits the generalizability of 
results to the broader population. Nonetheless, evidence does support the conclusion that GS 
does play a key role in controlling glycogen synthesis even when controlling for glucose uptake. 
Glycogen Synthase and Exercise 
Apart from the debate over the relative importance of glucose uptake versus GS activity 
in determining the rate of glycogen synthesis, another issue of importance in glycogen 
metabolism is the role of exercise in influencing glycogen flux, particularly in modulating the 
activity of GS and glucose transport. In the course of discussing this topic, the importance of 
glycogen content in skeletal muscle and the intracellular location of GS will also be mentioned 
since each relates to muscle contraction in regulating glycogen metabolism. 
GS activity has been shown in several studies to be regulated by muscle contraction (74, 
87, 88). Specifically, GS activity is increased after muscle contraction (87) and following 
exercise, glycogen synthesis is increased even in the absence of insulin (89, 90). The exact 
mechanisms underlying the increase in GS activity remain unclear. However, some authors 




effect of muscle contraction on GS might also be mediated by protein phosphatase 1 (PP1), 
which activates GS by de-phosphorylating GS at specific serine residues (93). 
While progress has been made in identifying possible mechanisms by which muscle 
contraction can stimulate GS and thereby increase glycogen synthesis, data has accumulated 
suggesting that the potency of exercise in modulating GS activity and glycogen synthesis might 
be the result of other factors not intrinsic to exercise per se.  Evidence from several studies 
indicates that the increase in GS activation observed with exercise is due not to a change in the 
phosphorylation state of GS brought about by exercise acting independently but rather by a 
decrease in glycogen content in the muscle as a result of glycogenolysis during the exercise bout 
(83, 87, 94). Clearly, glycogen content itself is a potent regulator of its own synthesis and there is 
data to show that glycogen content can override other regulatory factors in determining the rate 
of synthesis (94-98). 
A recent line of experimental inquiry has provided new insight into mechanisms 
regulating glycogen synthase. In their experiments with rats, Nielsen and colleagues reported that 
GS translocates from glycogen-rich membrane locations to the cytoskeleton in the skeletal 
muscle tissue of animals with low glycogen levels (94). The experiments also showed that high 
glycogen concentrations in skeletal muscle inhibited GS even in the presence of insulin, which is 
a potent activator of the enzyme. These experiments have pursued a theory, introduced as early 
as the 1960’s, that glycogen was present in dynamic cellular organelles called “glycosomes” 
(99). This concept proposes that the linkage of glycogen with its regulatory proteins is critical to 




Experiments by Prats (100) and Nielsen (94) have investigated the translocation of GS 
within the cell and the data from this work has lent support for the glycosome concept and for the 
notion that the translocation of GS in response to the changing energy state of the cell is an 
important regulatory mechanism in controlling glycogen synthesis and cellular energetics. In 
particular, the work of Prats and colleagues (100) showed that after the metabolic stress of 
glycogen-depleting muscle contraction, GS undergoes redistribution within the cell from the 
nucleus to spherical structures associated with the actin cytoskeleton. This occurred within 
glycogen-depleted muscle fibers in a refractory period, indicating that these fibers were in the 
early stages of metabolic recovery and glycogen resynthesis. These findings also comport with 
prior data showing that GS requires binding to glycogenin for efficient initiation of glycogen 
synthesis, considering that glycogenin and GS have been found associated with the actin 
cytoskeleton (94, 101, 102). 
The work done in the last two decades has provided much insight into the regulation of 
glycogen synthase by hormones, exercise, and glycogen content while leaving many questions 
yet unanswered. The mechanisms underlying the ability of muscle contraction to modulate GS 
remain unclear. Among the issues remaining unsettled is the exact nature of the relationship 
between contraction and PP1, the phosphatase that de-phosphorylates GS, thereby increasing GS 
activity. Indeed, data has accumulated calling into question the idea that muscle contraction 
independently activates GS, especially when glycogen content is high (83, 94). The role of GS 
movement within the cell in regulating glycogen metabolism is a topic only beginning to be 
studied systematically. Even the relative contribution of insulin to the overall regulation of GS is 
a subject of active investigation. The resolution of these questions will continue to present 




Glycogen Branching Enzyme 
Glycogen branching enzyme (GBE) completes the synthesis of glycogen by catalyzing 
the formation of alpha 1-6 linkages and thereby creating branch points in the growing glycogen 
molecule. GBE transfers chain fragments from glycogen by the cleavage of an alpha 1-4 bond 
from a donor, previously catalyzed by GS, to an acceptor via the formation of an alpha 1-6 bond 
(103). The acceptor may or may not be the original donor. The reaction catalyzed by GBE does 
not result in any net glycogen synthesis, but is only a transfer reaction that modifies the structure 
of the mature glycogen particle. 
One aspect of the physiological significance of the branched structure of glycogen is the 
enhanced solubility of glycogen conferred by branching. Without branching, the polysaccharide 
formed by GS precipitates and act as a foreign body within the tissues. Even though, according 
to the present state of knowledge about the degree of branching of glycogen, the alpha 1-6 
linkages constitute only approximately 10% of the linkages in glycogen (1), a deficiency in 
branching enzyme results glycogen storage disease type IV, which is fatal in humans, usually by 
four years of age. Glycogen storage disease type IV will be discussed in more detail in a later 
section. 
GBE has been studied extensively in clinical medicine and biochemistry due to its 
importance in determining the structure of glycogen and its significance as the cause of a severe, 
if rare, metabolic disease. The study of GBE in medicine and biochemistry has led to insights 
into the mechanism of action of the enzyme (104-107) and the development of improved assays 
for measuring the activity of the enzyme (106, 108). The bulk of the research effort into GBE of 




glycogen storage disease type IV during pregnancy. Case reports on such aspects as 
heterogeneity in presentation of the symptoms of glycogen storage disease type IV have also 
appeared in the literature (109-113). However, the enzyme has received almost no attention in an 
exercise context. 
Only one study in 1974 has examined GBE and its relationship to exercise (3). Taylor 
and colleagues reported that GBE activity is increased following a 12-week endurance cycling 
training program in a group of males ranging in age between 21-26 years. The participants were 
trained (n=8) and sedentary (n=8). Additionally, the authors noted that the activity of GBE 
decreased during prolonged sub-maximal exercise and then showed an increase in activity after 
the cessation of both prolonged sub-maximal exercise and maximal work to exhaustion. This 
pattern of activation corresponds to the activity of GS and is thought to be attributable to varying 
levels of insulin (114, 115). The findings of this study have not prompted any further 
investigation into the relationship between GBE and exercise. Of note in this particular study is 
the fact that the assay method for measuring branching enzyme activity was not described in any 
detail. A reference was made to a paper describing the method. However, the reference was 
listed as “in press” and was nowhere to be in found in the published literature after an intensive 
search. 
The observation that GBE activity increases in response to an exercise-training program 
could be of more significance than has been appreciated thus far. Perhaps the general acceptance 
that GS activity and glucose transport are the rate-limiting steps in glycogen biosynthesis has 
been responsible for the fact that GBE has eluded scientific inquiry relating to exercise and 
nutrition. However, the findings of Taylor and colleagues clearly provide at least preliminary 




rate-limiting in glycogen synthesis, the increase in GBE activity demonstrates that there is an 
investment of biological resources in increasing the amount of branching activity in parallel with 
the increased activation of GS during the rapid phase of glycogen repletion following exercise. 
Also, the finding that GBE activity increases following an exercise training program of 12 weeks 
indicates that the transcriptional machinery is activated, leading to an increase in the 
concentration of GBE within skeletal muscle in response to training. It is logical to conclude that 
such increases are of functional physiological significance. The enhanced solubility of glycogen 
conferred by additional branching would allow for more glycogen to be stored within the muscle. 
Also, the formation of more alpha 1-6 linkages results in an increased number of terminal 
residues incorporated into the mature glycogen granule. Glycogen phosphorylase and glycogen 
synthase both act on terminal residues. In this manner, branching increases both the rate of 
glycogen synthesis and the rate of degradation. This is one important functional consequence 
involving exercise of the finding that GBE activity is increased in response to training (3). 
Further data has accumulated in studies of genetically modified rodents indicating that 
GBE is of importance in regulating glycogen metabolism by ensuring that the structure of 
glycogen synthesized is properly branched. In mice modified to overexpress glycogen synthase, 
glycogen is not branched to the degree found in normal mice and polyglucosan bodies develop 
and precipitate within the tissues (116, 117). These findings occurred in animals that had no 
deficiency in GBE, at least in the sense that the mice did not have a mutation that caused a 
complete absence of GBE of the kind seen in type IV glycogen storage disease. On the other 
hand, the results indicate that even a mismatch between the relative activities of GS:GBE causes 
dysregulation of the degree of branching that results in malformed glycogen with a structure 




way that its activity remains proportional to that of GS. However, the control of the glycogen 
branching/debranching system remains poorly understood and is an area of glycogen metabolism 
that has not received the amount of attention that it probably merits. 
Another aspect to consider in a discussion of the significance of GBE pertains to 
glycogen storage disease type IV, which is caused by a deficiency of GBE. The disease was first 
reported by Andersen in 1956 (118). The patient presented with massive enlargement and 
cirrhosis of the liver, with autopsy showing an accumulation of an abnormal glycogen with a 
structure appearing similar to that of amylopectin (starch). The clinical progression of the disease 
results in liver failure causing death, usually by age 2 (119). Work done after the initial reports of 
the disease confirmed that the cause was an inherited genetic defect (autosomal recessive) 
resulting in an absence of GBE (120). 
Viewed in the light of the evidence accumulated from clinical medical research on 
glycogen storage disease type IV, the role of GBE in glycogen metabolism gains added 
perspective and significance. The severe clinical course of glycogen storage disease type IV 
shows that the action of the enzyme is necessary for life. The fact that GBE has not been viewed 
as rate-limiting in glycogen synthesis has perhaps diminished the attention paid to the enzyme 
while at the same time the severity of glycogen storage disease type IV has probably led to the 
emphasis of research on GBE to be focused on aspects of the enzyme related to clinical 
medicine. However, the one study performed by Taylor and colleagues did provide preliminary 
evidence that GBE increases in response to an exercise stimulus (3). Even if GBE is not rate-
limiting to glycogen synthesis in the strictest sense of the term, an increase in GBE reveals that 






Glycogen phosphorylase (GP) catalyzes the regulated step in the breakdown of glycogen. 
GP catalyzes the phosphorolysis of alpha 1-4-glycosidic linkages of glycogen, yielding glucose 
1-phosphate and shortened glycogen as its products (19). GP continues the phosphorolytic 
cleavage of alpha 1-4 linkages until it reaches a point 4 residues short of an alpha 1-6 linkage, 
the hydrolysis of which requires the action of a separate debranching enzyme. GP has been 
viewed classically as the rate-limiting enzyme in the breakdown of glycogen and the regulation 
of the enzyme has been the subject of intense investigation. 
The discovery of glycogen phosphorylase by the Carl and Gerta Cori was an epoch-
making event in history of biochemistry (121). GP was the first allosteric protein ever discovered 
and its study led to an understanding of mechanisms of general significance in biological 
science, such as allosteric activation and regulation of enzyme activity by reversible 
phosphorylation. Following the discovery of GP, for several years the enzyme was thought to be 
responsible for both the synthesis and degradation of glycogen (1). This view was revised when 
Leloir and Cardini first reported that glycogen synthase was the enzyme responsible for the 
synthesis of glycogen by adding glucose residues to the growing glycogen granule by the 
formation of alpha 1-4-glycosidic bonds with UDP-glucose as the activated glucose donor (2). 
The study of GP led to new vistas in the understanding of metabolic control systems, 
particularly allosteric control and covalent modification. GP has been studied in detail such that 
the catalytic mechanism of the enzyme is known in molecular detail. The three-dimensional 




the structure of the enzyme brought about by allosteric interactions and reversible 
phosphorylation are well understood. 
GP exists in two forms in three different tissues in humans; liver, muscle, and brain 
(122). Phosphorylase a is the active form of the enzyme which does not require AMP for 
catalysis to proceed, although AMP does augment the rate of the enzyme by roughly 10% (123). 
Phosphorylase b predominates in resting muscle and is in the inactive T state, requiring binding 
by AMP for transition to the active R state (124). The transition of phosphorylase b from the T to 
the R state is also controlled by phosphorylation at a single serine residue (serine 14) by 
phosphorylase kinase. Conversely, phosphorylase a is deactivated by hydrolysis of the 
phosphorylated serine residue by protein phosphatase 1 (PP1). Glycogen phosphorylase and 
glycogen synthase are thus coordinately regulated by reversible phosphorylation, with GS being 
relatively inactive while phosphorylated at the same time that GP is relatively active while 
phosphorylated. 
GP is also regulated by several other ligands and allosteric effectors. AMP, ATP, glucose 
6-phosphate, epinephrine, glucagon, and insulin all exert an influence on the activity of GP by 
changing the phosphorylation state, and thereby the inter-conversion of the enzyme between the 
a and b forms. AMP, epinephrine, and glucagon all signal that the energy state of the organism is 
low and that glycogen should be mobilized. Conversely, ATP, glucose 6-phosphate, and insulin 
signal that fuel is abundant and thereby activate glycogen synthase while simultaneously shifting 
the relative concentrations of GP so that the inactive b form predominates. 
Glycogen and glycogenolysis are important for exercise performance. Intense exercise 




mobilization of glycogen as a fuel for exercise is underscored by the exercise intolerance 
experienced by individuals suffering from glycogen storage disease type V, which is caused by 
an absence of GP, first reported by Brian McArdle in 1951 (128). Patients suffering from 
McArdle’s disease experience painful muscle cramps during exertion and are severely limited in 
their capacity for exercise. A 1972 study by Taylor and colleagues reported an increase in 
phosphorylase a following an endurance training program (129). 
During exercise, GP activity increases. GP is thought to be activated in skeletal muscle 
by exercise mechanistically by the contraction-induced elevation of Ca2+ causing an activation of 
phosphorylase kinase, which phosphorylates GP and in turn generates the active phosphorylase a 
(19). Epinephrine enhances the activation of GP by initiating the cAMP signaling cascade. 
cAMP is a potent intracellular messenger and an activator of GP. 
Glycogen Debranching Enzyme 
Glycogen debranching enzyme (GDE), also known in the literature as amylo-1,6-
glucosidase, 4-alpha-glucanotransferase (AGL), is a bi-functional enzyme acting in concert with 
glycogen phosphorylase to complete the degradation of glycogen. GP degrades the glycogen 
chains up until four glucosyl units before an alpha 1-6 branch point. GDE then carries out the 
transfer of three glucose residues from the short branch to the end of another branch using its 
transferase activity; the enzyme then hydrolyzes the alpha 1-6 branch point residue by using its 
amylo-1,6–glucosidase activity (130). For complete degradation of glycogen, the dual transferase 
and glucosidase activities of GDE and the activity of GP are required. Structural and biochemical 




revealed the enzyme to be a large monomeric protein having a molecular mass of 165-175 kDa 
(131-133). 
GDE has received almost no attention in exercise science. One study by Taylor and 
colleagues reported a two-fold increase in GDE activity following a 12 week endurance training 
program while observing that GDE activity decreased immediately following submaximal and 
maximal exercise to exhaustion (4). These observations were consistent with those of studies 
performed in the same laboratory with glycogen synthase and glycogen branching enzyme (3). 
The finding that an endurance-training program is associated with GDE activity increases along 
with that of phosphorylase indicates that the ratio of phosphorylase to debranching enzyme 
activity must be regulated in order for complete glycogen degradation. 
A deficiency in the debranching enzyme complex underlies glycogen storage disease type 
III (Cori’s Disease) (134). The lack of activity of GDE results in an incomplete breakdown of 
glycogen and glycogen accumulates. The glycogen stored in the tissues affected by the disease 
has very short outer chains. 
The clinical presentation of GSD-III is remarkably diverse (135). Most patients present 
with deficiency of the enzyme in liver and muscle and the disease is characterized by liver 
enlargement, hypoglycemia, and shortness in stature (136). In about 15% of patients, the disease 
appears to only involve the liver. Liver-related symptoms typically improve with age and resolve 
after puberty (137). Muscle weakness can occur in patients with a deficiency of GDE in muscle, 
with the severity of the weakness typically progressing in severity from very mild in childhood 
to severe after the third or fourth decade of life (138-140). The diversity of symptoms observed 




enzyme. Patients having both muscular symptoms and liver involvement seem to suffer from a 
generalized enzyme defect. In these patients, deficient enzyme activity also occurs in tissues 
such as the heart, erythrocytes, and cultured fibroblasts (141, 142). Patients have also been 
reported to have only liver involvement with no clinical or laboratory evidence of myopathy 
(136). There have been rare cases where selective loss of either the glucosidase activity or the 
transferase activity of the bifunctional has been demonstrated (135, 141). 
While the regulation of GDE remains obscure, the study of the enzyme in clinical 
medicine has demonstrated that the enzyme is important in the proper metabolism of glycogen. 
Also, the one study done by Taylor and colleagues did report that the enzyme does increase its 
activity in response to an endurance training program (4). The body of work on this enzyme 
supports the idea that the branching and debranching complexes of the glycogen cycle enzymes 
are important and that organisms relying on glycogen for metabolic energy regulate the ratios of 
the enzymes that are active in the processes of branching and debranching of glycogen. Despite 
this evidence, the relative paucity of investigation into both the branching and debranching 
enzymes is apparent, especially in comparison to the relatively large body of work done on 
glycogen synthase and, to a lesser extent, with glycogen phosphorylase. Further work into the 
regulation of glycogen branching and debranching enzymes would be desirable. 
Implications for Future Research 
In the decades since the discovery of glycogen phosphorylase in 1939, the study of 
glycogen and its metabolism has changed the fields of biology and clinical medicine. Discoveries 




AMP signal cascade, and hormonal control were all intimately related to investigations of 
glycogen synthesis and degradation. 
Despite so many decades of intense research effort, many gaps in our understanding of 
the regulation of glycogen metabolism still exist. Furthermore, there remains vigorous debate in 
such areas as whether or not glycogen exists as one species within the cell or as distinct 
metabolic entities clearly distinguishable by characteristics such as acid solubility and protein 
content. 
An area of critical importance in determining the structure and metabolic regulation of 
glycogen is the branching/debranching system. The fact that the key distinguishing characteristic 
separating glycogen from starch is the greater degree of branching found in glycogen is one point 
demonstrating the importance of branching. The lethality of glycogen storage disease type IV, 
caused by a deficiency of the branching enzyme, further underscores the significance of 
branching. Moreover, a deficiency of debranching enzyme causes glycogen storage disease type 
III, which has a milder clinical course and a greater diversity in clinical presentation than GSD-
IV, but nonetheless results in symptoms ranging from cirrhosis of the liver to cardiomyopathy in 
particularly severe cases. Aside from the glycogen storage diseases, it is also worth noting that a 
high degree of branching results in the formation of more terminal glucose residues incorporated 
into the mature glycogen granule. Both glycogen synthase and phosphorylase have their catalytic 
activity at the terminal residues, therefore the rate of both glycogen synthesis and breakdown 
would be accelerated by more branching. 
Despite these points, the roles played by branching and debranching enzyme in the 




science. There have been a total of two studies performed on both enzymes examining their 
relevance to exercise; both were published in the early 1970’s and the results have not stimulated 
any further interest, despite providing evidence that both enzymes increase following exercise 
training. Many questions remain open. Do the two enzymes differ in their concentrations in fast 
versus slow-twitch muscle? Since fast-twitch muscle is adapted to perform high-intensity 
exercise, it is reasonable to suggest that glycogen is a preferred fuel in fast-twitch muscle when 
compared to slow-twitch muscle. A finding of different concentrations of branching and de-
branching enzyme in the two different muscle types would be a novel finding that would add to 
the current state of knowledge in glycogen enzymology. 
The liver is also of interest as a site of possible differing concentrations of branching and 
de-branching enzyme. It could be expected to find higher concentrations of the two enzymes in 
the livers of animals that perform high-intensity, glycogen-depleting exercise due to the key role 
played by liver glycogen in buffering blood glucose levels during times of scarcity and exercise. 
However, we currently do not know whether or not this is true. Further questions of interest 
regarding the branching and de-branching system in the liver include determining whether or not 
diet has an effect. Dietary manipulation could exert an effect on glycogen branching structure 
independent of exercise by influencing the rate of flux through glycogen and thereby imposing a 
metabolic stressor on the enzymatic systems controlling the structure of glycogen. The 
potentially differing effects of a high-carbohydrate versus a low-carbohydrate diet on glycogen 
branching in the liver, is a topic that invites inquiry. Currently the scientific literature is silent on 
this subject. 
We also do not know if glycogen branching and de-branching enzymes vary in 




status. Two animal models are particularly attractive as candidates for investigation that could 
answer this question. Racehorses and dogs both represent a class of elite animal athletes that 
could provide a standard of comparison with their non-elite counterparts. Data suggesting a 
difference between the two groups could be extended to other species, including humans, which 
might open new vistas in understanding how glycogen responds to exercise. 
Glycogen branching and de-branching enzymes are essential to life in mammalian 
species. Clinical medicine has established that deficiencies in these enzymes are lethal. However, 
despite the vast amount of inquiry directed towards glycogen synthase and phosphorylase in 
regulating glycogen in clinical and exercise contexts, branching and de-branching enzymes have 
eluded investigation. The significance of these enzymes likely extends beyond the question of 
whether they are present or not. Glycogen is a molecule that is subject to elaborate regulation, 
representing a major investment of energy in the organism. Given the importance of glycogen as 
a nexus in bioenergetics and the essentiality of the branched structure of glycogen, the question 
of whether or not the enzymes controlling the branching and de-branching of glycogen are 




CHAPTER II – EXPERIMENTS 
 
Introduction 
The significance of the glycogen branching and debranching enzymatic systems in 
metabolism is made plain by the fact that a deficiency of either enzyme results in disease. In the 
case of a deficiency of branching enzyme, the clinical course of the disease is fatal, while a 
deficiency of debranching enzyme results in clinical outcomes varying in severity. Indeed, the 
single structural feature of glycogen that distinguishes it from plant starch is the greater degree of 
branching found in glycogen. 
Furthermore, the branching of glycogen makes glycogen more soluble in the cell and 
modifies the structure of the polysaccharide so as to create a greater number of non-reducing 
ends, which serve as a substrate for phosphorylase. This structural characteristic of branched 
glycogen allows for a more rapid degradation of glycogen in times of high metabolic demand 
and is thus adaptive for the organism. 
In spite of the importance of branching in glycogen metabolism, there has been a relative 
lack of scientific interest in the study of branching enzyme when compared with the voluminous 
body of literature that has developed surrounding enzymes such as glycogen synthase and 
glycogen phosphorylase. Although these enzymes are thought to be rate limiting in the 
biosynthetic and degradative arms respectively, of glycogen metabolism, there has been some 
evidence that branching enzyme is regulated in response to stimuli. 
Although preliminary, the few studies examining branching enzyme activity in 
experimental trials have lent support to the idea that branching enzyme is regulated in response 




to exercise was published in 1974 (3). Using human subjects, Taylor and colleagues reported that 
branching enzyme activity increased in response to exercise training. The method used to assay 
branching enzyme in this experiment was not made clear, however. The observed increase in 
branching enzyme activity reported in the 1974 study was related to an earlier study by the same 
authors (143) reporting that glycogen synthase activity increased in response to exercise training 
in parallel with branching enzyme. The implication of this relationship was that the activities of 
glycogen synthase and glycogen branching enzyme are regulated in response to exercise such 
that the ratios of the two enzymes remains intact and that the length of the α 1,4-glycosidic chain 
remains constant, along with the number of non-reducing ends in the glycogen macromolecule.  
Although the method of measuring the activity of branching enzyme was not clear in the 
1974 study, a subsequent study by Pederson and colleagues (117) using genetically modified 
mice provided evidence showing a relationship between overexpression of glycogen synthase 
and branching enzyme. In this study, mice overexpressing constitutively active glycogen 
synthase in skeletal muscle were shown to have elevated muscle glycogen and a decreased 
degree of branching. However, Western blotting showed that despite the decreased degree of 
branching observed, there was an increase in the level of branching enzyme expression and an 
approximately threefold increase in branching enzyme activity. Branching enzyme was assayed 
according to the method developed by Krisman (144), which uses an iodine staining reagent to 
determine the degree of branching colorimetrically using a spectrophotometer. 
The development of an assay for branching enzyme activity has posed challenges. 
Methods devised have included a periodate oxidation assay for end-group determination, which 
can provide the basis for a calculation of the average chain length of the branches in a 




involves the treatment of amylopectin (starch) with branching enzyme and determination of the 
degree of branching caused by the addition of branching enzyme by the decrease in absorbance 
of a colored complex of the polysaccharide and iodine reagent (144). Recognizing that the 
structural difference between glycogen and amylopectin is the degree of branching of each, it 
was noted that the two polysaccharides have different wavelengths of maximum absorption when 
stained with iodine and analyzed with a spectrophotometer. Amylopectin has a wavelength of 
maximum absorption of 520 nm while that of glycogen is 460 nm. The principle of the iodine-
staining assay is to take aliquots of a reaction mixture containing branching enzyme and iodine-
stained amylopectin at different time intervals and determine the decrease in absorbance of the 
colored complex at 520 nm. As the polysaccharide becomes more branched, absorbance at 520 
nm decreases. 
While this iodine method is specific for the activity of branching enzyme, it is neither 
quantitative nor sensitive. The method cannot give a specific quantity of branch points formed by 
the action of branching enzyme but can only determine that the degree of branching is more or 
less as indicated by the change in the color of an indicator. The method is also subject to 
interference from impurities in branching enzyme preparations or in the polysaccharide itself. 
Enzyme preparations and glycogen from tissue extracts are frequently contaminated with 
amylase, an enzyme that degrades polysaccharides by the hydrolysis of α-1,4-glycosidic bonds. 
The presence of this enzyme interferes with the measurement of branching enzyme by the iodine 
method because it degrades the polysaccharide at the same time it is being synthesized by the 
reaction mixture containing specific quantities of branching enzyme. While the assay can be 




the fact that the assay cannot directly quantify the number of α-1,6 branch points synthesized by 
branching enzyme specifically. 
An attempt was made by Krisman and colleagues to develop an assay for branching 
enzyme that is sensitive, specific, and quantitative (108). The basic procedure of the assay is to 
first synthesize a polysaccharide using a reaction mixture containing a small amount of glycogen 
as a primer with other reaction components necessary for the synthesis of complete 
macromolecular glycogen. The amount of purified branching enzyme added to the reaction 
mixture was varied and aliquots of the polysaccharide formed were taken and analyzed at 
intervals. The polysaccharide synthesized as described above was then purified and subjected to 
complete degradation by the combined actions of phosphorylase and debranching enzyme. The 
principle of the assay is to selectively quantify the glucose residues involved in branch points 
catalyzed by the action of the branching enzyme and express the degree of branching of the 
polysaccharide by comparing the number of the glucose residues bound to the polysaccharide by 
α-1,6-glycosidic linkages as a percentage of the total carbohydrate content of the polysaccharide. 
This is possible due to the differing products yielded by the catalytic actions of phosphorylase 
and debranching enzyme. 
In the degradation step mentioned above, the combined actions of phosphorylase and 
debranching enzyme are both necessary to break down glycogen, or any branched 
polysaccharide, completely. In the breakdown of glycogen specifically, it is significant that 
debranching enzyme yields free glucose by the hydrolysis of α-1,6-glycosidic bonds while the 
product of the phosphorylase reaction is the phosphorylated sugar glucose 1-phosphate. The 






Figure 2.1. The separate actions of amylo-α(1,6)-glucosidase and glycogen phosphorylase yield 
the different products, free glucose and glucose-1 phosphate, which are determined separately 
and compared using the assay developed by Krisman and colleagues. 
The two products formed by the reactions depicted above allow for the quantitative 
determination of the branch points because the free glucose yielded by the hydrolysis of the α-
1,4-glycosidic linkages is a reducing sugar while the glucose 1-phosphate yielded by the 
phosphorolysis of the α-1,4-glycosidic bonds is not a reducing sugar. Therefore, the 
measurement of reducing sugars in a sample obtained by the breakdown of purified glycogen is a 
measurement of the free glucose that can have come from no other origin but the α-1,6-linkages 




measured by an assay that is specific to the presence of such sugars can be compared to the 
quantity of total carbohydrate in the sample to give a percent degree of branching. 
The advantages of the assay are several. First, it is quantitative due to the fact that it 
measures directly the product formed by branching enzyme. The specificity of the assay is also 
desirable since a number of reducing sugar assays are available that are sensitive only to 
reducing sugars and no other carbohydrates. Krisman and colleagues also demonstrated in their 
study describing the development of the assay that the method shows a strict linear correlation 
with the number of glucose units linked by branch points and not the overall amount of 
polysaccharide synthesized in the reaction. This linear relationship holds even when the 
branching enzyme used in the reaction is known to be contaminated with amylase; the method 
therefore overcomes a common problem in measuring branching enzyme. This allows the 
method to be used in crude extracts in which amylase interference would otherwise be a problem 
in determining branching enzyme activity. Krisman and co-workers also indicated that the 
method is more sensitive than another quantitative assay developed decades ago, the periodate 
oxidation assay, which requires 25 times more polysaccharide for determination of the number of 
α-1,6-glucosyl residues than does the method described here. The periodate method also depends 
on the degree of branching of the polysaccharide under study, with lower degrees of branching 
requiring greater amounts of sample in order for the assay to detect the degree of branching 
(108). The assay is also inexpensive in terms of reagents and equipment. 
Since the development of Krisman’s method for the selective measurement of glucose 
residues from the branch points in a polysaccharide, the assay has been surprisingly little used 
when considering its advantages relative to other techniques. This should not be interpreted to 




scientific interest in studying branching enzyme when compared to other highly active areas of 
research pertaining to glycogen, such as glycogenin, glycogen synthase regulation, and the pro- 
and macro-glycogen debate. Regardless of the cause, only a few studies were undertaken to 
extend the results of the initial work done in developing the assay (146-148). These studies 
applied the assay to brain tissue and added insight into possible regulation of the enzyme, along 
with revealing more detail about the structure of glycogen. However, no attempt has been made 
to use the assay to develop a body of data on the degree of glycogen branching in a variety of 
species and tissues, nor has there been any application of the method in a clinical trial in which 
diet or exercise has been employed as an intervention to determine if branching enzyme is 
modulated in response to such stimuli. In recognition of the fact that only one study sought to 
examine the role of exercise in modulating branching enzyme (3), and that this particular study 
was unclear regarding the method used to assay the enzyme, there appears to be a gap in our 
understanding of branching enzyme from several vantage points. 
One area of interest would be to provide data from several samples of the same type of 
tissue in an animal model to get a more complete idea of the normative range of the degree of 
branching in tissues. Such data is completely lacking at the current time and would add to our 
understanding how glycogen structure might be different across a range of tissues and species. A 
particular area to investigate is whether or not the degree of branching of glycogen varies in 
tissues that are specialized for particular functions, such as fast twitch versus slow twitch muscle 
or in liver compared to muscle in general. 
Dietary manipulation is also an intervention that could shed additional light on how 
branching enzyme might vary in response to stimuli and possibly exert a heretofore 




speculative, there is a rationale for an up-regulation of branching enzyme being a facilitator in 
repletion of glycogen stores following depleting exercise or fasting. The additional solubility 
gained by incorporating more branch points into the structure of glycogen, along with the more 
ready availability of branched glycogen as a substrate for glycogen synthase and phosphorylase 
lend theoretical support to the idea that branching enzyme might be regulated. Data from a study 
with genetically modified mice indicates clearly that branching enzyme expression is increased 
when the animals overexpress an active form of glycogen synthase (117). The data from this 
particular investigation provides an intriguing set of data indicating a regulatory role for 
branching enzyme, but it is important to note that the method used to assay the enzyme was the 
iodine staining method (144), which is less sensitive than the method described above and is also 
not quantitative. 
The branching enzyme assay developed by Krisman might also be modified so as to 
increase its economy and simplicity. The reducing sugar assay method employed to quantify the 
number of glucose residues involved in branch points is that developed in the 1930’s by 
Somogyi (149). This colorimetric assay is sensitive and specific but requires intensive effort in 
the preparation of several reagents and is more time consuming and labor intensive than some 
other methods introduced in the many years since its original development. One such assay is the 
tetrazolium blue assay (150), developed in 1984. This assay uses a colorless, water-soluble 
tetrazolium salt as an indicator for the detection of reducing sugars in a sample. The tetrazolium 
reagent undergoes transformation to a water-insoluble formazan salt, which develops a blue 
color when heated for 30 seconds in the presence of a reducing sugar such as glucose. This 
colored compound is extracted from the aqueous component of the reaction mixture by the 




glucose concentration is then interpolated from a standard calibration curve. A detailed 
description of the assay principle and procedures follows in another section but the assay is more 
economical in terms of reagents and time than the Somogyi method while remaining sensitive 
and specific. 
The basic method developed by Krisman will be applied to a cohort of mice subjected to 
a dietary intervention. This study will aim to clarify the degree of glycogen branching in the liver 
tissue of an animal in which the enzyme has not yet been measured. From the application of this 
method, a set of new normative data will be developed which will help to clarify the structure of 
glycogen in the mouse liver. Furthermore, the experiments described below will seek to 




The laboratory animals and dietary and quercetin supplementation procedures described 
here were developed and implemented in their entirety by Henagan and colleagues (151). Liver 
tissue specimens were a generous gift of Dr. Laura Stewart. 
 The Male C57BL/6J mice (n = 240) (Jackson Laboratory, Bar Harbor, ME) were 
obtained and weaned onto a high carbohydrate diet (Research Diets, New Brunswick, NJ). The 
high carbohydrate diet had a fat content of 10% of kcals from fat. At 6 weeks of age, the mice 
were randomly assigned in equal numbers to one of the following diets, the fat content of each 
diet is indicated according to percent of kcals in the diet from fat: 1. High carbohydrate (HC) 




+ Q500) (45% kcals fat + 500 μg/mouse/day), 4. Low carbohydrate + quercetin (LC + Q250) 
(45% kcals from fat + 250 μg/mouse/day), 5. Low carbohydrate + quercetin (LC + Q50) (45% 
kcals fat + 50 μg/mouse/day). The groups are summarized in the table (Table 2.1) below. 
Table 2.1 Summary of experimental diet and supplementation protocols 
Treatment Group Fat Content of Diet (% of kcals in diet) 
Quercetin Dose 
(µg/mouse/day) 
Number of Animals in 
Group 
HC 10% - 48 
LC 45% - 48 
LC + Q500 45% 500 48 
LC + Q250 45% 250 48 
LC + Q50 45% 50 48 
 
Mice were quartered individually in shoebox cages with corncob bedding. Temperature 
was controlled (22°C). The light: dark cycle was maintained at 12 : 12 hours. All experiments 
were reviewed and approved by the Pennington Biomedical Research Center Institutional 
Animal Care and Use Committee. 
Diets and Food Consumption 
The procedures described in this section pertaining to diets and food consumption were 
developed and implemented in their entirety by Henagan and colleagues. 
Quercetin > 98% (HPLC) was purchased from Sigma Aldrich (St. Louis, MO) and LC + 
Q diets were stored at 4°C in light-protected, airtight containers. Food was changed every 3 days 
and water was provided ad libitum. Food consumption was measured on a weekly basis in 16 




each treatment group. Food consumption was measured by weighing food before and after a 48 
hour period each week. 
Isolation of Liver Glycogen 
At 3 weeks and 8 weeks, mice were euthanized and immediately post-mortem the livers 
from the experimental animals were harvested and immediately snap frozen in liquid nitrogen. 
After freezing, the tissues were stored at -80°C until ready for further analysis. 
The basic steps in isolating liver glycogen consist of digestion of the tissue in hot 
concentrated alkali, in this case potassium hydroxide (KOH), followed by precipitation of the 
glycogen with ethanol (152). The detailed procedure is outlined below (145). 
A sample of liver tissue was dropped into a previously weighed glass test tube containing 
3 ml of 33% KOH solution.  The tube was then weighed once again and the weight of the sample 
determined by the difference (n = 138, 265.1 mg ± 110 mg). The tube was then immersed in a 
boiling water bath for 20 to 30 minutes. Following tissue digestion, the tube was vortexed briefly 
and 0.5 ml of saturated sodium sulfate was added. The glycogen was then precipitated by the 
addition of 4 ml of 100% ethanol.  This mixture was then vortexed briefly before the tube was 
then reheated until the mixture began to boil. The tube was then removed from heat and cooled 
on ice for 15 minutes. Following cooling, the mixture was centrifuged for 15 minutes at 3000 
rpm. The alcoholic supernatant was then decanted and the test tube allowed to drain. The 





Purification of Glycogen Debranching Enzyme 
Debranching enzyme was not routinely available commercially and was therefore 
partially purified from dog muscle until the 41% ammonium sulfate fractionation step as 
described by Brown and Brown (153). 
The details of the purification procedure are described below. Dog muscle was obtained 
by a generous donation of the Calcasieu Parish Animal Shelter in Lake Charles, Louisiana. 
Animals from which muscle samples were collected were euthanized by phenobarbital injection. 
Immediately post-mortem muscle samples were dissected from the quadriceps and triceps brachii 
and frozen at -20°C until ready for further processing. 
The frozen dog muscle was kept overnight at 6°C so that it partially thawed in 
preparation for homogenization. The homogenization procedure was carried out in a cold room 
at 6°C. The partially frozen muscle samples, weighing approximately 1 gram each, were placed 
in a glass test tube in 3 ml of cold distilled water and the cells disrupted by a Brinkmann 
Polytron PT 10/35 homogenizer (Brinkmann, Switzerland). Following cell lysis, the crude 
extract was centrifuged (Sorvall) at 23,000 g for 1 hour at 4°C. The precipitate was discarded and 
the supernatant was adjusted to pH 6 with 2 M sodium acetate buffer, pH 4.5. The supernatant 
was then centrifuged again at 10,000 g for 15 minutes at 4°C and the precipitate was discarded. 
The supernatant was then neutralized to pH 7.0. 
After adjusting to pH 7.0, the neutralized solution of 450 ml initial volume was made 
41% saturated in ammonium sulfate by the slow addition of 108 g of solid ammonium sulfate as 
the solution was stirred. The solution was allowed to stand at 4°C for 2 hours, after which time 




was discarded and the precipitate was suspended in 5mM Tris-1 mM EDTA-5 mM β-
mercaptoethanol, pH 7.2. This solution was then dialyzed for several hours against frequent 
changes of the buffer. Following this step, the precipitate was collected by centrifugation at 
10,000 g for 15 minutes at 4°C. The precipitate was re-suspended in buffer and then frozen in 
aliquots at -80°C for later use. The protein concentration of the preparation was determined by 
Bradford Assay to be 1.09 μg/μl. 
Tetrazolium Blue Assay for Reducing Sugars 
The tetrazolium blue assay was originally developed as a sensitive reducing sugar assay 
to measure the cellulolytic activity in bacterial cultures. The method is based on the formation of 
a colored formazan salt when colorless tetrazolium salt is reduced in the presence of a reducing 
sugar such as D-glucose, first observed by Cheronis (154). 
The colored formazan salt is water insoluble and has a wavelength of maximum 
absorption of 570 nm. The assay allows for simple determination of reducing sugars with a 
spectrophotometer.  The assay used in this investigation takes advantage of a modification 
introduced by Mullings and Parish (150), which adds a toluene extraction step. The addition of 
the toluene extraction step uses the solubility of the colored formazan salt in organic solvent to 
overcome problems encountered in quantifying the reducing sugars colorimetrically in the 
aqueous layer caused by the particulate nature of the substrate. The method is sensitive and 
specific. It is also simple and economical in terms of reagents when compared to other reducing 
sugar assay methods, such as the Nelson-Somogyi assay (155). The details of the assay 




The tetrazolium blue reagent was prepared by adding three volumes of 0.3 M NaOH to an 
aqueous suspension of tetrazolium blue chloride (1% w/v, 1 volume) (Sigma Aldrich, St. Louis, 
MO) and stirring until completely dissolved. Five volumes of distilled water were then added 
and the reagent stored at 5°C in the dark. For each assay 0.1 ml of sample and 0.9 ml of 
tetrazolium reagent were mixed in a tube and then immersed in a boiling water bath for 30 
seconds. The tubes were allowed to cool to room temperature and then 1.5 ml of toluene was 
added to each tube. Each tube was then shaken using a vortexer. The shaking was repeated until 
no more color was removed from the aqueous layer. 1 ml of the toluene layer was then placed 
into a quartz cuvette by pipette and absorbance at 570 nm was recorded. Reducing sugar 
concentration in the sample was quantified from interpolation from a standard curve with D-
glucose as the reference standard. The calibration curve for D-glucose, using least squares 
analysis to give the best fit to points, is shown (Figure 2.2) below. 
 





























The assay demonstrated sensitivity to a lower detection limit of 80 μM of D-glucose. The 
calibration curve was calculated using the mean value of five replicates for each D-glucose 
concentration. The intraclass correlation coefficient was 0.99. 
Phenol Sulfuric Acid Assay 
The phenol sulfuric acid assay for total carbohydrate is one of several assays based on the 
action of concentrated sulfuric acid that causes the hydrolysis of glycosidic linkage. The 
hydrolyzed neutral sugars (pentoses and hexoses) are then partially dehydrated, with the 
elimination of three molecules of water, to form furfural or a derivative of furfural. 
Furfural and its derivative cause condensation with a number of several phenolic 
compounds such as phenol (156), α-naphthol, orcinol (157), and anthrone (158) to form colored 
compounds (159). The particular phenolic compound used in this experiment was α-naphthol 
(Molisch’s reagent), which reacts positively with all carbohydrates and forms a purple colored 
product with a wavelength of maximum absorption of 490 nm. Details of the procedure are 
below. 
Table 2.2. Various colorimetric assays for sugars based on phenolic compounds (adapted from 
reference 159) 
Name of Test Phenol Concentrated Mineral Acid Positive Reaction 
Color of 
Product 
Molisch’s α-naphthol H2SO4 All carbohydrates Purple 
Seliwanoff’s Resorcinol HCl Ketoses and sucroses Red 
Bial’s Orcinol HCl Pentoses and uronic acids Green 






Molisch’s reagent is prepared by making a 5% w/v solution of α-naphthol in 100% 
ethanol. 200 μl of the reagent is added to a glass test tube and mixed with 200 μl of glycogen 
sample. For this experiment, three replicates of 200 μl each were taken from the glycogen 
isolated from the liver of each animal. 1 ml of concentrated sulfuric acid was then added rapidly 
and directly on the sample without allowing the acid to touch the side of the tube. The solution 
was left undisturbed for 10 minutes and was then vortexed. Following vortexing, the solution 
was incubated for another 30 minutes. 1 ml was then taken from each tube and then placed in a 
fresh polystyrene cuvette. Each sample was then read by a spectrophotometer (Shimadzu UV-
160) at 490 nm and the carbohydrate concentration determined from a standard plot. The 
standard calibration curve was calculated using D-glucose as the reference. Five replicates were 
used for each concentration and the mean of the replicates for each concentration used as the 
standard. The calibration curve is shown below (Figure 2.3.) 
The samples developed color with an optical density that exceeded the linear working 
range of the assay. Therefore each sample was diluted so that the absorbance was within the 
working range of the assay and the concentration was then determined by interpolation from the 
standard curve, taking the dilution factor of each sample into account when making the 
calculation. The calibration curve showed linearity within a working range from 40 μM up to 
1.28 mM. The lower limit of detection observed during development of the standard plot was 40 






Figure 2.3. Calibration curve for the phenol sulfuric acid assay for total carbohydrate 
Preparation of Reagents for the Determination of the Degree of Branching 
Purified AMP (Sigma A2252) was obtained by purchase from Sigma Aldrich (St. Louis, 
MO). The AMP was solubilized in cold distilled water and ammonium hydroxide, which was 
added drop-wise to the cold stirring mixture of AMP and distilled water until the AMP was 
completely dissolved. The solution was then adjusted to pH 7.0 and frozen in aliquots at -80°C 
until ready for use. As noted in the section entitled purification of glycogen debranching enzyme, 
debranching enzyme was not available commercially and was therefore purified from dog 
muscle up to the 41% ammonium sulfate fractionation step by the procedure of Brown and 
Brown. Phosphorylase b (Sigma P6635) was purchased from Sigma Aldrich (St. Louis, MO) and 
was solubilized in 0.6 M potassium phosphate buffer, pH 7.0. The solution was frozen in aliquots 





























Determination of Degree of Branching of Mouse Liver Glycogen 
To determine the degree of branching in the mouse liver glycogen samples under study, a 
modification of the procedure developed by Krisman (108) was used. This procedure has the 
advantages of being sensitive, specific, and quantitative. It is also economical in terms of 
equipment and reagents and is well suited to measurement of branching enzyme activity in crude 
extracts due to the observation by Krisman and colleagues that the method overcame interference 
by amylase-type degrading enzymes (108). The specific measurement of branching enzyme 
activity in mouse liver was carried out by the following procedure described below: 
A. Purification of glycogen from mouse liver. 
Mouse liver tissue extracts had been kept frozen at -80°C and glycogen was purified from the 
tissue by the methods described in detail in the section above entitled isolation of liver glycogen. 
Briefly, the glycogen samples were placed in 3vol of 33% KOH and heated in a water bath at 
100°C for 20-30 minutes, until complete digestion. 4 ml of 100% ethanol and 0.5 ml of saturated 
sodium sulfate was added to the digest to precipitate the glycogen. Following centrifugation for 
15 minutes at 3000 rpm, the precipitate was collected and the supernatant was discarded. The 
precipitate was solubilized in 2 ml of distilled water. 
B. Measurement 
To determine the number of glucose residues involved in the branch points the glycogen was 
degraded by the coordinate action of phosphorylase b and debranching enzyme. The reaction 
mixture contained 200 μl of the purified glycogen, 60 mM potassium buffer with 21.66 μl of 
phosphorylase b (Sigma P6635, Sigma Aldrich, St. Louis, MO) dissolved in the buffer, pH 7.0, 5 




preparation purified from dog muscle (0.85 mg of protein, as determined by the Bradford Assay). 
The reaction mixture was brought up to a final volume of 1300 μl by the addition of distilled 
water. The reaction mixture is summarized in the table (Table 2.3) below. 
Table 2.3. Summary of reaction mixture for degradation of glycogen purified from mouse liver 
Reaction Component Concentration in Stock Solution 
Concentration in 
Reaction Mixture 
Volume of Stock 
Solution Added to 
Reaction Mixture 
(µl) 
Potassium phosphate buffer 
with dissolved Sigma P6635 
phosphorylase b, pH 7.0 
600 mM 
 





AMP (Sigma) 50 mM 5 mM 130 
Debranching Enzyme 1.09 μg/μl 0.85 mg of protein 780 
Glycogen from Mouse Liver Unknown Sample Unknown Sample 200 
Distilled H2O - - 60 
Final Volume   1300 μl 
 
The reaction mixture was combined in a 2.0 ml microfuge tube and incubated for 3 hours 
at 37°C in a water bath. Following incubation, the reaction was stopped by the addition of 3 vol 
of 100% ethanol. After centrifugation at 200 rpm for 15 minutes in a micro-centrifuge 
(Eppendorf, Germany), a precipitate layer was observed at the meniscus slightly above the 400 
μl mark of the tube. Two aliquots of 100 μl were taken from the bottom layer of the mixture, 
below the precipitate layer, and added to glass test tubes for measurement of reducing sugar by 
the tetrazolium blue assay. 
The glucose measured in these aliquots was then compared to the total carbohydrate in 
separate aliquots of the purified glycogen isolated from the same liver by the phenol sulfuric acid 




linked by α 1,6-glycosidic linkages measured by the tetrazolium blue assay (150) and the total 
carbohydrate determined by the phenol sulfuric acid method (159). 
Experiment 1 
Experimental Approach to the Problem 
The development of an assay for glycogen branching enzyme has faced challenges over 
several decades. One of the first experimental approaches to the problem was the periodate 
oxidation method, which gives a measurement of the number of non-reducing end glucose units 
in the glycogen macromolecule (160). The principle of the assay is based on the observation that 
when six-carbon sugars are attacked by periodate the ring structure is disrupted with the removal 
of the third carbon atom as formic acid. After periodate oxidation of glycogen, the quantitative 
determination of the formic acid produced by the reaction allows for a calculation of the average 
chain length of the branches in the glycogen. This method, although in general agreement with 
other methods (108, 161), is time consuming and depends on the color change of an indicator. 
Accurate determination of the degree of branching also is also dependent on the structure of the 
polysaccharide under analysis, with polysaccharides with low branch content requiring up to 25 
times the amount of polysaccharide required when compared to the method developed by 
Krisman (108). 
Another method developed to assay the activity of branching enzyme is the iodine-
staining method of Krisman (144). This method works by incubating amylopectin with 
branching enzyme and measuring the decrease in optical density at 520 nm, the wavelength of 
maximum absorption of amylopectin. As catalysis by branching enzyme proceeds, the 




maximum absorption shifts toward 460 nm, the wavelength of maximum absorption of glycogen. 
This method is specific and rapid. However it is essentially non-parametric and therefore cannot 
provide a quantitative determination of the activity of branching enzyme and rather can only give 
a relatively greater or lesser degree of activity of branching enzyme as the optical density of the 
polysaccharide changes as the degree of branching changes. 
Krisman and colleagues developed a method to measure the activity of branching enzyme 
by selective quantitation of the α-1,6-linked glucose residues involved in the branch points (108). 
This assay is sensitive, specific and quantitative. The assay synthesizes a polysaccharide using 
known quantities of purified glycogen branching enzyme and then completely degrades the 
synthesized polysaccharide. The number of α-1,6-linked glucose residues are measured in the 
reaction mixture as reducing sugars and this is compared to the amount of total carbohydrate 
determined by the phenol sulfuric acid assay (156) to yield a percent degree of branching. The 
determination of the number of glucose residues involved in the branch points by measuring 
reducing sugars in the reaction mixture of degraded glucose is valid due to the fact that free 
glucose, which is a reducing sugar, can come from no other origin than a branch point. This free 
glucose is a product of the action of debranching enzyme, which hydrolyzes α-1,6-glycosidic 
linkages selectively. All other carbohydrate degraded in the reaction mixture is glucose-1 
phosphate, which is liberated by the action of phosphorylase and is not a reducing sugar. The 
assay method therefore compares metabolically distinct carbohydrates from known origins in the 
glycogen macromolecule and expresses a percentage of free glucose as a constituent of the entire 
glycogen molecule. 
The method of Krisman and colleagues has only been applied (146-148) in a few 




has the method been used to assay branching enzyme activity in any particular animal model in 
repeated trials that could build up a set of data that would allow conclusions about norms of 
branching enzyme activity to be developed. The reliability and reproducibility of the method has 
also not been tested. Moreover, while the method is simpler and less time consuming than the 
periodate oxidation method in particular, it is noteworthy that the reducing sugar assay employed 
by Krisman is the Somogyi-Nelson method (149). This method was developed in 1933 and, 
despite its sensitivity and specificity, might be a less attractive method for the determination of 
reducing sugars than some alternative procedures developed in the decades since its inception. 
One such assay is the tetrazolium blue assay, developed in 1984 by Mullings and Parish (150). 
This method is very economical in terms of reagents and provides results in less than an hour. 
The assay is sensitive and specific to reducing sugars. 
In this experiment, the method of Krisman and colleagues will be used to measure the 
degree of branching in the liver glycogen from mice. This is the first experiment performed using 
this assay method in mouse liver. The sample size used in the experiment is larger than in any 
study previously done using the method. The reliability and reproducibility of the assay will also 
be tested for the first time. Also, the use of the tetrazolium blue assay for reducing sugars instead 
of the Somogyi-Nelson method is a new adaptation of the original method used by Krisman and 
is simpler, more economical, and less time consuming than the Somogyi-Nelson method. 
Methods 
The experimental procedures for the experiment are outlined in detail above. Briefly, 
liver samples (n = 68) from mice were collected and analyzed for the degree of branching of 




(108) was used, with the modification that the tetrazolium blue assay for reducing sugars was 
used instead of the Somogyi-Nelson method. 
The degree of branching is reported as a percentage based on the ratio of reducing sugars 
assayed by the tetrazolium blue assay to the total carbohydrate content measured by the phenol 
sulfuric acid assay (156). 
 Statistical Analysis 
A major aim of the study is to test the reliability of the assay method. Therefore, optical 
density of the samples assayed by the tetrazolium blue and phenol sulfuric acid assays were 
measured in duplicate and triplicate, respectively. The reducing sugar and total carbohydrate 
content were determined from the mean optical density of the replicates of each assay and were 
determined mathematically by interpolation from a standard calibration curve developed in our 
laboratory using known glucose concentrations as the standards. The calibration curve for each 
assay was developed using five replicates for each glucose concentration with the mean optical 
density of the replicates as the value for each concentration of glucose. The optical density was 
measured using a Shimadzu UV160-U UV-VIS spectrophotometer (Shimadzu, Columbia, MD). 
To test the reliability of the assays, intraclass correlation coefficients (ICC) were 
determined for the replicates of the tetrazolium blue assay and the phenol sulfuric acid assays; 
ICC values were obtained for each assay both for the calibration curves and the measurement of 
carbohydrate content in the liver samples. Degree of branching for all 68 mice was measured and 
the results reported as mean ± standard deviation. All statistical procedures were completed 






The assay procedures demonstrated a high degree of reliability for each of the assay 
conditions, measuring glucose concentrations for the development of standard plots and 
measuring the carbohydrate content of the liver samples. Table 3.1 below shows the ICC values 
for each assay. The mean degree of branching for the 68 mice under study was 13.14 ± 8.71 
percent. 
Table 2.4. Intraclass correlation coefficients for the tetrazolium blue and phenol sulfuric acid 
assays 
Assay and Condition ICC 
Phenol – H2SO4 for Liver Samples 0.925 
Phenol – H2SO4 for Standard Calibration Curve 0.998 
Tetrazolium Blue for Liver Samples 0.848 
Tetrazolium Blue for Calibration Curve 0.99 
 
Calibration curves developed for each assay calculated from known concentrations of D-
glucose are shown in figures 2.5 and 2.6 below. 





























Figure 2.5. Calibration curve for the phenol sulfuric acid assay 
Discussion 
The aims of the present study were mainly to apply the branching enzyme assay 
developed by Krisman and extend its application to a new animal model. This experiment also 
used a large sample size in an effort to determine the degree of branching of glycogen in mouse 
liver and also made an initial effort to assess the reliability of the assay. The values for the 
degree of branching found in the current study (13.14 ± 8.71%) are in approximate concordance 
with values reported by Krisman and Tolmasky (9.4% for rabbit liver glycogen) (108). The 
degree of branching reported in this study is also roughly similar to that reported in a standard 
biochemistry textbook (119), which was expressed as “about 1 in 10 residues is branched.” For 
direct comparison, 13% degree of branching would correspond to a ratio of 1 in 7.7 residues 
being branched. It is important to note, however, that the extent of agreement with the previous 





























knowledge. Previous work done using the method did not report results with any indication of 
the variance found in the degree of glycogen branching among the animal and plant specimens 
assayed. It is unclear from the previous work how many different animal samples were tested 
since the authors did not report the degree of branching in terms of means with measures of 
variance. Instead, the values were reported singly for each plant or animal tissue under study 
(108, 148). 
This experiment also used a simpler and more economical reducing sugar assay than the 
Nelson-Somogyi method, which was employed in the original development of the assay. Along 
with the effort to establish a framework of normative data within which to view the degree of 
branching of mouse liver glycogen, data has been presented on the reliability of the assay 
method. This report also makes clear the degree of reliability and linearity of the standard plots 
used to quantify reducing sugars and total carbohydrate in the liver samples; an accurate measure 
of these quantities depends entirely on the accuracy of the calibration curves used to interpolate 
these values. The results reported here are intended to facilitate comparisons of various protocols 
to assay glycogen branching enzyme and thereby advance the aim of accurately measuring the 
enzyme in a way in which valid comparisons of the activity of the enzyme can be made across 
different tissues and species. At the current time, this is not possible due to a lack of comparable 
data in the literature. 
The results of the statistical analyses performed in the present study indicate that the 
assay procedure demonstrates a high degree of reliability. The intraclass correlation coefficients 
for the tetrazolium blue assay for reducing sugars and the phenol sulfuric acid assay for total 
carbohydrate when used to develop standard calibration curves and to measure carbohydrates in 




stable when measured with multiple replicates (ICC’s were 0.99, 0.848, 0.998, and 0.925 
respectively). It is also important to note that the numbers of replicates for each tetrazolium and 
phenol sulfuric acid assay are clearly reported in this study in an effort to enable the protocols 
described here to be repeated independently without confusion. 
One of the difficulties in developing the assay used in the present study was the lack of 
information providing any indication of the actual levels of reducing sugars or total carbohydrate 
one could expect to find in the samples under study. This complicated efforts to develop the 
calibration curves for D-glucose upon which accurate measurement of reducing sugars and total 
carbohydrate depend. The process of developing calibration curves with the reliability and 
linearity required for accurate measurement of carbohydrates in the samples required many 
repetitions of the assays before standard plots were generated that captured the optical densities 
measured in the tissue samples under study. Even after extremely high linearity (R2 = 0.9913 for 
the tetrazolium assay and R2 = 0.9993 for the phenol sulfuric acid assay) was attained for the 
calibration curves across a wide range of glucose concentrations (40 μM – 1.28 mM), it was 
necessary to perform dilutions and back calculations in order to measure the total carbohydrate 
by the phenol sulfuric acid assay due to the extremely high optical density in the undiluted 
samples. The dilution factors necessary for obtaining optical density readings within the working 
range of the assay ranged from 4X to 50X. By including the calibration curves and making clear 
that dilutions were required we hope to facilitate efforts to replicate the procedures here with a 
view toward refinement of the method. 
The decision to use the tetrazolium blue assay to measure reducing sugars in the present 
study was made in order to increase the economy of the assay procedure in terms of cost, 




(150) when first reported in the literature. The reducing sugar assay developed by Somogyi in 
1933 (149) has been used for several decades and is time-honored for its sensitivity and 
reliability but it requires more reagents and is more complex than the tetrazolium assay. These 
characteristics provide an incentive to adopt a simpler method, which the tetrazolium blue assay 
offers. The assay was quite new at the time Krisman and Tolmasky first reported their method 
and it is possible that during the time these authors were developing their procedure for 
measuring branching enzyme they were as yet unaware of the assay. 
The high degree of reliability of the tetrazolium assay reported here should offer 
encouragement for researchers to further test the assay in terms of its applicability to measuring 
branching enzyme activity. The sensitivity of the tetrazolium assay measured in our laboratory 
was comparable to that reported by Mullings and Parish in the original report describing the 
procedure, with linearity in our standard curve found at a lower limit of 80 μM of D-glucose 
compared to 100 μM reported by Mullings and Parish (150). Achieving reliable results with the 
tetrazolium assay might require some repetition for those inexperienced in its use. In samples 
with only monosaccharides, the heating time of 30 seconds can probably be exceeded without 
any threat to validity. This is due to the fact that extended heating time will cause alkaline 
hydrolysis of oligosaccharides, which can cause inaccuracies when the intent of the procedure is 
to measure only reducing sugars such as glucose. While we endeavored to be precise in keeping 
the heating time at 30 seconds, any deviation from that standard did not necessarily threaten the 
accuracy of our results since any alkaline hydrolysis of pure glycogen would result in the release 
of glucose, which was the sugar we intended to measure. 
Another inherent source of variability in measuring reducing sugars using the tetrazolium 




The procedure involves repeated shaking of the reaction mixture, which is composed of an 
aqueous layer and a toluene layer, which are distinct due to the fact that toluene and water are 
not miscible. The formazan salt formed by the reduction of tetrazolium blue in the presence of a 
reducing agent such as glucose is insoluble in water and highly soluble in toluene. However, 
repeated agitation of the sample is required in order for the toluene to completely extract the 
colored product. Repetition of the assay is required in order to accurately determine when the 
color is completely extracted into the toluene layer, which is above the aqueous layer due to its 
relatively low density compared to water. It is worth noting that the toluene extraction step was 
an improvement introduced by Mullings and Parish when they developed the assay based on the 
initial observation by Cheronis (154) that tetrazolium could be used to quantify reducing sugars. 
Observations in our laboratory confirm that the assay overcomes the problem of the particulate 
nature of the formazan salt when it is confined to the aqueous layer. When the colored formazan 
salt is suspended in the toluene layer, the high degree of solubility of the formazan salt in toluene 
leads to the formation of a very clear solution with no particulate matter. Measurement of the 
optical density of the colored product in the toluene layer is thus more accurate than it would be 
in the aqueous layer due to the particulate nature of the substrate in aqueous solution. 
An important aim of the present study was to employ a large sample size of glycogen 
specimens in an effort not only to test the reliability of the assay with multiple iterations but to 
supply data which could be used to draw some conclusions about norms of branching enzyme in 
the mice under study. Moreover, the testing of the degree of branching enzyme in a large set of 
subjects offers some data about the variability of the degree of glycogen branching across 
animals of the same species in the same tissue, mouse liver in this case. Also, the report here of a 




values found for other tissues and species reported by Krisman and colleagues (146, 148). These 
authors found degrees of branching of 9.4%, 10.7%, and 7.9% in glycogen from rabbit liver, rat 
brain, and oyster, respectively. The reports of Krisman and colleagues do not contain data on 
samples sizes used nor do they report the degree of branching as means ± standard deviation. It is 
therefore impossible to draw any conclusions from these reports on the variability of branching 
enzyme activity with respect to different tissues and species. 
In the present study we find that the average degree of branching of mouse liver glycogen 
in the 68 animals studied to be 13.14 ± 8.71 percent. This is the first study to our knowledge to 
report on a sampling of subjects of this size and the first to report average values of the degree of 
branching in the same type of tissue from so many different animals of the same species. On the 
basis of this, there is at least some preliminary evidence that the degree of branching in mouse 
liver exhibits a rather high degree of variability across individual animals. When examined 
together considering the data reported here on the reliability of the assay, it seems fair to 
conclude that the degree of branching in the glycogen samples under study was accurate at least 
in terms of accurate measurement of the reducing sugars and total carbohydrate, which are the 
variables necessary to measure in order to ascertain a degree of branching. It is necessary to 
consider other steps in the procedure that could have introduced uncontrolled variability into the 
measurement, however. 
The isolation of the glycogen from each liver sample is a procedure that involves steps 
that can cause variability from one tissue extract to the next. While the digestion of the tissue 
extracts in hot alkali is a time-honored practice that denatures glycogen-degrading proteins and is 
generally not subject to variability across different extracts, the ethanol precipitations and re-




across samples and investigators. The decision of how many ethanol precipitations to perform 
before the glycogen is suspended in water is not entirely clear-cut and therefore could create 
variability. The amount of time between the extraction of the liver tissue from the mice and the 
snap-freezing in liquid-nitrogen also could affect the glycogen concentration in the liver samples. 
Glycogen degrading enzymes remain active at temperatures down to -60°C and therefore it is 
possible that some of the glycogen from the samples could have been broken down prior to snap-
freezing if the samples were not frozen in liquid nitrogen immediately upon dissection. If some 
of the glycogen from the tissue samples was lost due to post-mortem degradation, the degree of 
branching might have been affected due to the activities of glycogen phosphorylase and de-
branching enzyme. It is difficult to say exactly how the degree of branching would be affected by 
such glycogen breakdown, with the understanding that different relative activities of 
phosphorylase and de-branching enzyme would alter the degree of branching in opposite 
directions if either enzyme predominated. 
The degree of branching could also be affected by how complete the degradation of the 
glycogen was when subjected to the action of phosphorylase b and de-branching enzyme in the 
reaction mixture designed to degrade the glycogen in preparation for the tetrazolium assay. The 
incubation time and reaction mixture were in exact accordance with the procedures detailed by 
Krisman and Tolmasky. The authors noted that the reaction conditions used in their assay 
method resulted in near complete degradation of the glycogen into free glucose and glucose-1 
phosphate, as determined by radioactive tracer studies on 14-Cglucose used to synthesize the 
polysaccharide that was subsequently degraded using the same procedure as in the present study. 
This study replicated the reaction procedure used by Krisman and Tolmasky to the highest 




reasonably assured to be of the highest purity attainable. The only exception to this was the de-
branching enzyme preparation, which was not available commercially and therefore was isolated 
from dog muscle according to the procedure of Brown and Brown (153), which was the same 
method employed by Krisman and Tolmasky to obtain de-branching enzyme in their original 
study. 
The procedure for the purification of the de-branching enzyme from muscle extracts is a 
rather lengthy one when taken to completion, but for the assay of branching enzyme, it is only 
necessary to proceed to the 41% ammonium sulfate fractionation step in order to replicate the 
assay procedure of Krisman and Tolmasky. It is important to note here that the assay does not 
require a minimum level of purity as such, but rather it requires a certain level of protein content 
(0.85 mg). This requirement was fulfilled in our assay procedure as the Bradford assay (162) for 
total protein content was used to determine with precision the protein content of the de-branching 
enzyme preparation purified from dog muscle in our laboratory. The amount of de-branching 
enzyme added to the reaction mixture was determined so that exactly 0.85 mg of total protein 
was introduced into the mixture. All other reaction components were adjusted to accommodate 
this amount of de-branching enzyme preparation while keeping the molarity of all the other 
components in exact agreement with the procedure of Krisman and Tolmaksy. 
As an additional control step to verify that the de-branching enzyme was active, a 
reaction mixture containing a blank replacing the de-branching enzyme preparation with distilled 
water was used as a comparison. The mixture was identical to the one outlined by Krisman and 
Tolmasky with the exception that the de-branching enzyme was not present. The reaction 
mixture containing the blank was negative for reducing sugar when tested with the tetrazolium 




sugar, confirming that the de-branching enzyme preparation from our laboratory was active. We 
were therefore certain to an acceptable degree that the actions of phosphorylase and de-
branching enzyme were complete and the glycogen from each sample was completely degraded. 
The main objectives of the present study were to extend the applications of the branching 
enzyme assay developed by Krisman and Tolmasky to a large sample size of mouse liver 
samples in an effort to gain normative data about branching enzyme activity and to gain 
information that would allow some quantification of the reliability of the assay method. To this 
end we reported a high degree of reliability of the assay method not only in measuring the degree 
of branching in the samples but also in the development of the calibration curves used to quantify 
reducing sugars and total carbohydrate, which are the two variables required to determine the 
degree of branching. The number of replicates for each test was clearly reported to facilitate 
repetition of our procedures. The average degree of branching of a large number of subjects was 
reported that gives some normative data about the degree of branching of mouse liver glycogen 
and the variability of the measurement across different samples of the same tissue within one 
species. The degree of branching can thus be compared to the values reported by Krisman and 
Tolmasky with a view toward expanding the data available for estimating norms for glycogen 
branching enzyme across species and tissues. Finally, the assay method of Krisman and 
Tolmasky was modified with the intent of simplifying and economizing the procedures by using 






Experimental Approach to the Problem 
The branched structure of glycogen is critical to proper metabolic function in animals. 
Absence of glycogen branching enzyme is an inherited error of metabolism resulting in 
Glycogen Storage Disease Type IV (GSD IV), which in humans is fatal, usually by age 2 (163). 
While the clinical significance of an inherited deficiency in glycogen branching enzyme has been 
generally recognized by researchers active in the study of carbohydrate metabolism, there has 
been comparatively little interest in studying whether branching enzyme activity and/or 
concentration differs in subjects not suffering from GSD IV. Rather, much of the research effort 
directed toward studying branching enzyme has aimed at developing and refining clinical testing 
procedures for GSD IV (164). 
The body of scientific inquiry into the regulation and modulation of branching enzyme 
activity is scant. One study by Taylor and colleagues investigated the response of branching 
enzyme to an exercise training regimen in human subjects (3). The study found that branching 
enzyme activity increases in response to chronic exercise but the method used to assay branching 
enzyme was not made clear in the study. Pederson and colleagues found that in mice 
overexpressing constitutively active glycogen synthase there was a concomitant increase in 
branching enzyme expression and activity, but not of a magnitude sufficient to prevent the 
accumulation of abnormal glycogen in skeletal muscle, which precipitated and acted as a foreign 
body in the tissue (117). Interestingly, the livers of the transgenic mice did not appear to be 
affected. This study, however, used the iodine staining method of Krisman (144) to assay the 
activity of branching enzyme. This method uses the long-established observation that the degree 




The method, however, is essentially non-parametric and therefore cannot provide a quantitative 
determination of branching enzyme activity, although the method is specific and rapid. 
Krisman and Tolmasky developed an assay method that is specific, sensitive, and 
quantitive (108). The method selectively quantifies the glucose residues from α-1,6-linkages 
from the branch points and compares the number of such glucose residues to those from total 
carbohydrate content of the same glycogen sample. This value is then expressed as the 
percentage degree of branching in the glycogen particle and is a parametric value that can be 
compared quantitatively to values obtained by the same method across any range of branched 
polysaccharide samples. 
The method of Krisman and Tolmasky could be a significant improvement in the 
measurement of glycogen branching enzyme. However, the method has not been employed 
extensively. In particular, it would be of interest to use the method to explore whether branching 
enzyme increases in response to dietary intervention, since dietary intake modulates the rate of 
glycogen synthesis and concentration in tissues. The present study aims to determine whether or 
the relative percentages of carbohydrate and fat in the diets of mice has an effect on the degree of 
branching of mouse liver glycogen. The method of Krisman and Tolmasky will be used to 
determine the degree of branching, with a modification of the protocol that simplifies the assay 
and is less expensive in reagents and is less time consuming (150). 
Methods 
A detailed account of the experimental procedures has been given above. Briefly, mice 
were fed a high carbohydrate (n = 29) and low carbohydrate diet (n = 39) and were euthanized at 




activity using selective measurement of the glucose residues involved in the branch points 
expressed as a percentage of the total carbohydrate content of the glycogen sample under study. 
 Statistical Analysis 
The degree of branching of the glycogen samples from the LC- and HC-fed mice livers 
were compared using a t-test. Glycogen concentration of the liver samples of the two groups was 
also compared. The level of statistical significance was set a priori at P ≤ 0.05. Statistical testing 
was performed using SPSS version 20 (Chicago, IL). 
Results 
Analysis of the data did not show a statistically significant difference in the degree of 
branching between the LC- and HC-fed mice (P = 0.87). The degree of branching between the 
two groups actually showed a surprisingly high level of agreement (LC x̄ = 13.06 ± 8.68, HC x̄  
= 13.41 ± 8.68). The difference in glycogen concentration was also found not to be statistically 
significant (P = 0.28). 
Table 2.5. Comparison of Degree of Branching and Glycogen Concentration - values are mean ± 
SD. 
 High Carbohydrate Low Carbohydrate 
Percent Degree of Branching 13.41 ± 8.68 13.06 ± 8.68 
Glycogen Concentration (μmol) 2476.6 ± 1633.5 3080.7 ± 2998.6 
 
Discussion 
The results of the test of degree of branching in LC- and HC-fed mouse livers did not 




activity of branching enzyme between the two groups. An additional finding was that the 
difference in glycogen concentration between the two groups was not statistically significant. 
It might be expected that a high carbohydrate, and consequently high carbohydrate, might 
promote greater flux through glycogen and therefore would be stimulatory to the enzymes 
governing the rates of glycogen biosynthesis. The literature abounds with evidence that high 
carbohydrate intake promotes a higher rate of glycogen synthesis than that observed with a low 
carbohydrate diet, particularly when replenishment of depleted glycogen stores following 
strenuous exercise is studied. 
This study is the first to apply the assay method developed by Krisman and Tolmasky to 
a large group of subjects in a clinical intervention. Previous work in our laboratory has provided 
evidence that the assay procedure shows a high degree of reliability and it was therefore of great 
interest to apply the technique in an interventional study design to determine whether there were 
differences in branching enzyme brought about by different diets. The data did not reveal 
significant differences in the degree of branching of glycogen between the two groups. However, 
it is interesting to note a few points. 
The relative agreement in the measurement between the two groups adds to the body of 
data gathered thus far in evaluating the assay method and provides an enhanced frame of 
reference for comparison to values found in other species and tissues in the original study 
published that made the assay method known (108). The present study found that the degree of 
branching of the liver samples of both groups was approximately 13 percent. This value is not far 




and Tolmasky. Other samples measured in that study include oyster glycogen (7.9 percent), 
amylopectin (5.7 percent), and the limit dextrin of rabbit liver glycogen (15.6 percent). 
While the values reported by Krisman and Tolmasky do give a framework in which to 
place the values found in the current study, it is noteworthy that the data provided by Krisman 
and Tolmasky in the two studies in which they employ their method (108, 148) do not specify 
the sample sizes used in their protocol, nor is there any data reported on variance in their study. 
In the present study, a high degree of variance was observed in the degree of branching in both 
experimental groups. This could indicate that branching enzyme activity is more heterogeneous 
across individual animals than the results of previous work might lead one to conclude. In fact, 
throughout the rather scant body of literature reporting on branching enzyme, there are no studies 
that use sample sizes as large as that in the current study and no study has been encountered thus 
far that reports on the variability found in measurements of the enzyme. 
Of additional interest is the observation that the glycogen concentrations found in the 
liver samples of the two groups did not differ significantly. It is difficult to account for this 
finding in light of the evidence that a high carbohydrate diet tends to promote higher glycogen 
storage than does a low carbohydrate diet. In an effort to use the largest sample sizes possible for 
the study, mice that were euthanized at different times in their life span and at different times of 
day were pooled into two groups with respect only to the types of diet they consumed. Had a 
significant difference between the groups been observed, such a finding would have been very 
robust given the relative heterogeneity of the two groups in attributes other than diet. 
The relationship between glycogen concentration and the degree of branching has been of 




example, Pederson and coworkers found that mice overexpressing constitutively active glycogen 
synthase demonstrated a concomitant increase in branching enzyme activity and expression 
(117). The increase in branching enzyme was of insufficient magnitude to prevent the 
accumulation of abnormal glycogen that precipitated in skeletal muscle, but not in liver. In the 
present study, it was of interest to determine if any relationship between glycogen concentration 
and degree of branching would be observed. If there had been a higher number of branch points 
found in parallel with a higher concentration of glycogen, a reasonable explanation for the 
finding would be that the ratio of elongation activity of glycogen synthase is matched and varies 
positively with the activity of branching enzyme. This would have been in agreement with the 
findings of previous work (3, 117, 143). However, the findings of the current study indicated that 
the degree of branching was very similar among HC- and LC-fed mice and likewise the glycogen 
concentration did not differ significantly between the groups. 
This investigation into whether or not a dietary intervention is associated with a change in 
the degree of glycogen branching did not support the hypothesis that such a relationship exists. 
Results of this study indicate that the degree of branching of mouse liver glycogen is similar, 
although slightly higher, to that reported by Krisman and colleagues for rabbit liver glycogen and 
rat brain (108, 148). The study also did not observe any significant differences in liver glycogen 






Experimental Approach to the Problem 
The second of the three experiments detailed here explored the possibility of a 
relationship between diet and the degree of branching in mouse liver. The third experiment will 
examine whether or not the dietary supplement quercetin, in conjunction with different diets, has 
a measureable effect on the degree of branching in the mouse liver. 
Quercetin is a flavonoid found widely in nature. A body of evidence has emerged 
indicating that quercetin might have beneficial effects on some biological parameters related to 
health. Anti-inflammatory properties have been reported (165). A positive effect has also been 
observed on mitochondrial biogenesis (166). However, there is some evidence that quercetin can 
aggravate insulin resistance in liver brought about by a low-carbohydrate diet (167). 
The development of insulin resistance in liver is of interest as it pertains to the 
metabolism of glycogen. One of the most important functions of the liver is to synthesize 
glycogen and export glucose liberated from its own glycogen stores to other tissues in times of 
high metabolic demand. Insulin promotes an increase in the rate of glycogen biosynthesis in the 
liver and the development of insulin resistance is an impediment to the proper functioning of the 
liver as a repository of glycogen. 
It would be of interest to determine if metabolic perturbations to the liver brought about 
by insulin resistance would have a modulatory effect on glycogen structure in the liver. To this 
end, the present study aims to test whether different dietary intakes, in conjunction with different 
dosing regimens of quercetin, affect the degree of branching in the liver glycogen of mice 
subjected to such treatment. The degree of glycogen branching might well be negatively 




resistance developed in the liver. To address this question, several different dosages of quercetin 
were administered within the same mouse model to determine its effect on liver glycogen 
structure as it pertains to the degree of branching of liver glycogen. 
Methods 
A detailed account of the procedures used in the experiment is given above in the 
extended methods section previously in the document. A brief summary of the methods follows 
below. 
Mice were weaned onto a high carbohydrate diet for 6 weeks and were then randomly 
assigned in equal numbers to the experimental groups summarized in the table below. 
Table 2.6. Summary of the diets and quercetin dosing regimens of the subjects 
Treatment Group Fat Content of Diet 
(% of kcals in diet) 
Quercetin Dose 
(µg/mouse/day) 
Number of Animals 
in Group 
HC 10% - 48 
LC 45% - 48 
LC + Q500 45% 500 48 
LC + Q250 45% 250 48 
LC + Q50 45% 50 48 
 
At 3 weeks and 8 weeks, mice were euthanized and liver samples were harvested at the 
zenith (n=8) and the nadir (n=8) of the metabolic cycle and immediately snap-frozen in liquid 
nitrogen for measurement of the degree of glycogen branching by the procedure detailed in the 




 Statistical Analysis 
The data were analyzed with SPSS version 20 (Chicago, IL) and the results are expressed 
as means ± standard deviation. Measurements were evaluated using a one-way ANOVA. If 
significance was detected between the means by ANOVA, a post-hoc test was used to determine 
which groups were significantly different from one another. In this case, the assumption of 
homogeneity of variances between the different groups was not fulfilled. Therefore the Welch 
and Brown-Forsythe robust tests for equality of means were used to test for statistical 
significance. The Games-Howell post-hoc test was used to determine which groups were 
significantly different from each other. The threshold for statistical significance was set at P < 
0.05 a priori. 
Results 
A statistically significant difference (p = 0.042) was observed between the low-
carbohydrate diet group supplemented with 500 μg of quercetin that was euthanized at night at 8 
weeks versus the low-carbohydrate diet group supplemented with 500 μg quercetin euthanized 
during the day at 8 weeks. No other statistically significant differences were observed. 
Table 2.7. Percent degree of branching - values are means ± SD. (* denotes p < 0.05) 
Treatment Group Degree of Branching 
8W Day LC 500 7.27 ± 2.69* 
8W Night LC 500 21.16 ± 6.99* 
8W Night LC 9.71 ± 7.98 
3W Day LC 50 13.20 ± 10.17 
8W Day LC 50 16.75 ± 8.47 
3W Day HC 13.48 ± 10.84 
3W Night HC 7.83 ± 7.35 
8W Day HC 14.52 ± 8.24 





The only interaction between the treatments and the degree of branching appeared to be 
between the groups supplemented with 500 μg/day and euthanized at 8 weeks. The only 
difference between the two groups was the time in the metabolic cycle during which they were 
euthanized. Descriptive statistics for all the mice cohorts are compiled and tabulated in the 
appendix (pp.106 – 108). 
A possible explanation for this observation is that the one group was replete with liver 
glycogen while the other was depleted. Mice are typically most active at night and therefore feed 
at that time. It would therefore be expected that at the end of the dark cycle that the liver 
glycogen of the animals would be at its peak. However, there were no significant differences in 
liver glycogen concentrations observed between any of the experimental groups. It would 
therefore be highly speculative to propose an explanation of for the cause of this difference 
between these two groups. 
It is essential to note that the high variance in the degree of liver glycogen branching 
observed in all groups of mice in this experiment. It is also important to recognize that each 
cohort of mice was no larger than 8 individuals. In some cases, due to errors in measurement 
there was attrition in some groups that resulted in there being fewer than 8 individual mice in a 
group. Combined with the high degree of variance observed in the degree of branching, the 
relatively small sample size of each group undoubtedly limited the power of the study to detect 
any differences between the groups. 
This is the first study to apply a quantitative assay of branching enzyme to a prospective 




this procedure were intended mainly to test the method and to use the assay to learn more about 
the biochemical mechanisms involved in glycogen branching rather than to assess whether or not 
the enzyme is regulated or changes in response to various metabolic stimuli. 
While the results of the current study do not provide convincing evidence that glycogen 
branching enzyme activity is modulated in response to diet or quercetin supplementation in 
mouse liver, the assay method does offer some potential in measuring the enzyme in other 
contexts in which the experimental design is optimized to reveal changes in the activity of the 
enzyme. 
Possible areas of interest might include extending the use of the assay to different tissues 
such as different fiber types of skeletal muscle, which differ in metabolic profile and glycogen 
content. Given the increasing prevalence of metabolic syndrome and diabetes, a protocol that 
measures the enzyme’s activity in diabetic versus healthy animals with a large sample size might 
reveal differences in the degree of glycogen branching that accompany perturbations in 





The study of glycogen has led to discoveries of general significance in biochemistry and 
clinical medicine. Since the discovery of the glycogen molecule by Claude Bernard in 1870 to 
the pioneering discoveries of Carl and Gerty Cori, whose efforts identified glycogen 
phosphorylase, the first allosteric protein ever studied, the study of glycogen has revealed new 
vistas that have led to advances applicable to all areas of biological science. Following upon the 
trail blazed by the Coris, Luis Leloir discovered the enzyme that catalyzed the key step in 
glycogen synthesis, glycogen synthase. Not only did work of Leloir provide the key to 
understanding the synthesis of glycogen, but his experiments also led to an understanding of the 
essential role played by nucleotide sugars, which not only are activated donors in glycogen 
synthesis but key structural elements in DNA and RNA. 
Of critical importance in glycogen structure is the branching of the molecule. The only 
difference in the chemical structures of plant starch and animal glycogen is the different degree 
of branching in each polysaccharide, with glycogen being more branched than its plant 
counterpart, amylopectin. The branched structure of glycogen is critical to proper metabolic 
function in animals. The absence of glycogen branching enzyme, which is inborn error of 
metabolism, results in glycogen storage disease type IV, which is invariably fatal in humans, 
usually by age 2. 
Given the crucial importance of glycogen branching in metabolism, it would be 
reasonable to conclude that this feature of glycogen structure would draw significant scientific 
interest. In a way, that statement is true. In clinical medicine, tests for branching enzyme have 
been developed that can differentiate whether or not the enzyme is completely absent. This is of 




comparison with the massive effort directed at understanding the regulation of glycogen synthase 
and phosphorylase. 
As a consequence of this relative lack of interest in glycogen branching enzyme, there 
have been relatively few efforts to develop assay methods to measure the activity of the enzyme. 
The most frequently employed assay procedure, to the extent that the enzyme has been studied at 
all, was a procedure developed in 1962 to measure the enzyme based on the observation that the 
degree of branching of glycogen influences the absorption spectrum of glycogen intercalated 
with iodine. This method is not parametric, however, and therefore does not measure the enzyme 
quantitatively. This makes it impossible to compare values obtained from different tissues and 
animal specimens. 
The development of a quantitative method for the assay of glycogen branching enzyme 
took a further two decades following the iodine staining assay. In 1985, Krisman and Tolmasky 
published a study reporting their development of an assay procedure that was sensitive, specific, 
and quantitative. The method directly measured the degree of branching by accurately and 
selectively measuring the glucose residues linked to the glycogen molecule by α-1,6-glycosidic 
linkages and expressing the degree of branching as the ratio of these glucose residues as a 
percentage of total carbohydrate. The development of this assay offers a way of measuring 
branching enzyme that allows numerical comparisons of the degree of branching across species 
and tissues. 
Up to the current time, this assay has not been utilized to give an idea of the degree of 
branching in the glycogen of different animals and tissues. Therefore, we still have no concept of 




also allows determination of variability in glycogen branching among various tissues and 
species. The series of experiments detailed in this document took up the task of applying this 
assay method to liver samples of mice, an experimental model that had not been examined 
before. Other key objectives included measuring the reliability of the assay and examining 
whether or not dietary intervention and nutritional supplementation resulted in any modulation of 
the enzyme. The assay was also modified to economize the use of reagents and reduce the time 
necessary for the collection of data. 
The first experiment measured the degree of glycogen branching in the largest sample of 
subjects yet assembled for the study of the enzyme. Detailed data were reported that quantified 
the reliability of the assay and found that the assay technique developed in our laboratory 
demonstrates a high degree of reliability. The experiment also provided data on the variability of 
the degree of branching of glycogen in mice and gave an average value of the degree of 
branching found in 68 mice. The second experiment sought to determine whether or not a dietary 
intervention could modulate the activity of the enzyme. Results indicated that mice fed a low 
carbohydrate diet did not statistically differ from this fed a high carbohydrate diet. Finally, the 
third experiment analyzed whether or not diet and quercetin supplementation in conjunction 
would exert an effect on the activity of glycogen branching enzyme. Results of this experiment 
mainly failed to find statistically significance differences, except in the case of two of the several 
groups studied. The difference observed between these two groups was difficult to interpret. 
One of the points of interest revealed in the experiments is the degree of variability in the 
degree of branching in mouse liver glycogen. The variance from one animal to the next in terms 
of both glycogen concentration and degree of branching were both rather high. In liver tissue, 




cycling through synthesis and degradation due to the fact that the liver functions to supply other 
tissues with glucose in times of need. Depending on the time liver tissue is harvested, whether or 
not the animal under study had exercised recently, and feeding habits, liver glycogen stores can 
be expected to vary substantially between individuals. Perhaps it should therefore come as no 
surprise that the variability of liver glycogen concentration and degree of branching observed in 
the current study was rather high in relation to the mean values of each reported here. 
Skeletal muscle remains an attractive target for investigation of whether or not branching 
enzyme is modulated whether chronically, acutely, or both. Although Taylor did not report on 
the method used to assay branching enzyme activity in his 1974 study (3), it is of interest that the 
study reported an increase in branching enzyme activity in response to a chronic exercise in 
skeletal muscle. It is also important to note that in Pederson’s study of transgenic mice 
overexpressing glycogen synthase the observation of increased glycogen branching enzyme 
activity took place only in skeletal muscle and not in the liver (117). Application of the assay 
method used in the present study could very well find different results in skeletal muscle than 
those found in liver. In the present study, the animals were fed ad libitum and were not on any 
exercise regimen. These conditions did not place any metabolic stress on the animals and 
therefore it would not be expected that the glycogen stores of these animals were depleted. An 
experimental design that subjected participants to glycogen depleting exercise on a repeated 
basis or one that examined groups of elite athletes for the degree of branching in skeletal muscle 
might reveal differences in glycogen structure that can be quantified and compared across 
multiple studies. Understanding that skeletal muscle glycogen stores are sequestered within the 
sarcoplasm and not available for export to other tissues, it follows that intramuscular glycogen 




metabolic perturbations such as intense exercise or prolonged fasting. We should also expect to 
find lower variability in skeletal muscle glycogen stores both in terms of glycogen concentration 
and degree of branching. With this expectation, differences in the degree of branching would be 
more readily detected. Together with large sample sizes, experiments investigating the degree of 
branching of skeletal muscle glycogen would be a logical and useful extension of the methods 
employed in the present study. 
The reliability of the assay developed in the course of these experiments should 
encourage further efforts to apply the assay in new contexts. The cohorts of mice investigated in 
these experiments were not assigned in a way that was optimized to the purpose of discovering 
differences in the degree of glycogen branching. The relatively small sample size of each cohort 
(n=8), limited the power of the study to detect any differences between the groups.  
The assay could find fruitful applications in animal models that examine the effect of 
exercise, disease, and different tissue types. It would be of interest to determine whether or not 
the degree of branching varies in different muscle fiber types since fast and slow muscle fibers 
have different metabolic profiles and especially differ in their relative reliance on glycogen as a 
metabolic fuel. Investigations into the role of exercise in modifying glycogen branching would 
also add to our understanding of how glycogen structure responds to exercise. Finally, with 
recognition of the prevalence of diabetes and metabolic syndrome in our society, progress should 
be made in furthering our understanding of how the structure of glycogen might vary in the liver 
and muscle tissue of healthy subjects compared to those suffering from metabolic disease. Given 
the position of glycogen at the nexus of metabolism, the possibility that this readily mobilized 
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APPENDIX – DESCRIPTIVE STATISTICS FOR ALL MICE COHORTS 
3Week Day Kill LC 50      8 Week Night Kill LC 500 
           
Mean  13.20383086      Mean  21.15734579 
Standard Error  3.596147596      Standard Error  2.855010036 
Median  10.30401066      Median  21.4133556 
Mode  #N/A      Mode  #N/A 
Standard Deviation  10.17144141      Standard Deviation  6.993317799 
Sample Variance  103.4582203      Sample Variance  48.90649384 
Kurtosis 
‐
1.205700673      Kurtosis  1.437228816 
Skewness  0.579586826      Skewness 
‐
0.933600029 
Range  27.43340268      Range  20.16956431 
Minimum  1.114853608      Minimum  9.110185168 
Maximum  28.54825629      Maximum  29.27974948 
Sum  105.6306469      Sum  126.9440748 
Count  8      Count  6 
Confidence 
Level(95.0%)  8.503537818     
Confidence 
Level(95.0%)  7.339036939 
           
           
8 Week Day Kill LC 50      3Week Day Kill HC 
           
Mean  16.75950906      Mean  13.48088686 
Standard Error  2.994079155      Standard Error  3.833941034 
Median  14.94668495      Median  9.516012994 
Mode  #N/A      Mode  #N/A 
Standard Deviation  8.468534697      Standard Deviation  10.84402282 
Sample Variance  71.71607991      Sample Variance  117.5928308 
Kurtosis 
‐
0.402652143      Kurtosis 
‐
1.996413272 
Skewness  0.618757133      Skewness  0.424503103 
Range  25.30257195      Range  26.68680317 
Minimum  5.452235772      Minimum  2.179538323 
Maximum  30.75480772      Maximum  28.86634149 
Sum  134.0760725      Sum  107.8470949 
Count  8      Count  8 
Confidence 








         
Mean  7.267723722    Mean  9.713333547 
Standard Error  0.950268448    Standard Error  2.821877396 
Median  6.715779173    Median  7.680621145 
Mode  #N/A    Mode  #N/A 
Standard Deviation  2.687765054    Standard Deviation  7.981474569 
Sample Variance  7.224080988    Sample Variance  63.70393629 
Kurtosis 
‐
0.759563896    Kurtosis  2.280643328 
Skewness  0.569382741    Skewness  1.435816077 
Range  7.812973683    Range  24.59652777 
Minimum  3.942163303    Minimum  1.789537835 
Maximum  11.75513699    Maximum  26.38606561 
Sum  58.14178978    Sum  77.70666838 





         
         
3 Week Night Kill HC    8 Week Day Kill HC 
         
Mean  7.825342582    Mean  14.52005865 
Standard Error  2.780491853    Standard Error  3.363701624 
Median  6.100691017    Median  13.51917721 
Mode  #N/A    Mode  #N/A 
Standard Deviation  7.356489967    Standard Deviation  8.239352626 
Sample Variance  54.11794463    Sample Variance  67.88693169 
Kurtosis  5.192031292    Kurtosis  ‐0.32190902 
Skewness  2.181293298    Skewness  0.244551027 
Range  21.82250066    Range  23.22967236 
Minimum  1.95458912    Minimum  3.329174092 
Maximum  23.77708978    Maximum  26.55884645 
Sum  54.77739807    Sum  87.12035191 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